63
WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 1 MI4A Vaccine Purchase Data for Countries This note is intended to guide countries in their use of the MI4A vaccine purchase data. What data is available? The WHO vaccine market intelligence database compiles vaccine purchase (product, price and procurement) data as reported by countries via the WHO/UNICEF Joint Reporting Form (JRF) over the period of 2013–2018. While country names are not displayed, data is publicly available on the MI4A website and provides information by country characteristics (e.g. region, income group…) by vaccine and by year of purchase, along with price per dose (USD), procurement mechanism and annual volumes. The number of countries reporting vaccine purchase data through the JRF continues to increase year after year, with 182 Member States (93%) reporting some vaccine procurement information in 2019 – including 158 (81%) fully reporting on vaccine purchase data. Price reporting this year marks a 3% increase from last year and more than triple the reporting from 2016. Most importantly, full reporting from non-Gavi self-procuring countries who tend to have less access to market information increased by 12% compared to last year. Six countries also reported price for the first time this year. The largest proportion of non-reporting countries are high-income countries, with 20% having never reported any market information. The majority of these countries are in the European region. WHO encourages all countries to share vaccine purchase data. This will allow for a complete global market view, identifying risks to vaccine access without underrepresenting certain market segments. New questions were included in the 2019 JRF to support efforts on prospective data collection and have better visibility on countries’ future plans – for 1 Also refer to the guidance note on How to interpret the data: factors to consider when comparing vaccine price https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/factors_to_consider.pdf?ua=1 new vaccine introductions, but also for product switches – and to understand the status of product registrations. Fifty-six Member States responded to these new questions. This information is essential to WHO’s efforts to improve global market forecasts and inform suppliers’ and global policy-makers’ investment decisions. WHO encourages all countries to report information on new introduction plans and planned product changes as well as to respond to questions related to registration. How can my country use this data? 1 Countries can use the vaccine purchase data in several different ways, such as to: Understand how the price of vaccines in their immunization schedule relate to other products on the market, or compare the prices paid by other countries in similar conditions (e.g. income, funding/procurement group, contract conditions) – for example: how much does seasonal flu vaccine cost in countries similar to mine? Identify other vaccines available from a given manufacturer for example, what products are in the portfolio of a manufacturer of interest for my country? Understand other available products and presentations for each vaccine for example, which BCG vaccine products are on the market? Develop budget estimates to inform new vaccine introduction product choices, planning and budgeting

MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 1

MI4A Vaccine Purchase Data for Countries This note is intended to guide countries in their use of the MI4A vaccine purchase data.

What data is available? The WHO vaccine market intelligence database compiles vaccine purchase (product, price and procurement) data as reported by countries via the WHO/UNICEF Joint Reporting Form (JRF) over the period of 2013–2018. While country names are not displayed, data is publicly available on the MI4A website and provides information by country characteristics (e.g. region, income group…) by vaccine and by year of purchase, along with price per dose (USD), procurement mechanism and annual volumes.

The number of countries reporting vaccine purchase data through the JRF continues to increase year after year, with 182 Member States (93%) reporting some vaccine procurement information in 2019 – including 158 (81%) fully reporting on vaccine purchase data. Price reporting this year marks a 3% increase from last year and more than triple the reporting from 2016.

Most importantly, full reporting from non-Gavi self-procuring countries who tend to have less access to market information increased by 12% compared to last year. Six countries also reported price for the first time this year.

The largest proportion of non-reporting countries are high-income countries, with 20% having never reported any market information. The majority of these countries are in the European region.

WHO encourages all countries to share vaccine purchase data. This will allow for a complete global market view, identifying risks to vaccine access without underrepresenting certain market segments.

New questions were included in the 2019 JRF to support efforts on prospective data collection and have better visibility on countries’ future plans – for

1 Also refer to the guidance note on How to interpret the data: factors to consider when comparing vaccine price https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/factors_to_consider.pdf?ua=1

new vaccine introductions, but also for product switches – and to understand the status of product registrations. Fifty-six Member States responded to these new questions.

This information is essential to WHO’s efforts to improve global market forecasts and inform suppliers’ and global policy-makers’ investment decisions. WHO encourages all countries to report information on new introduction plans and planned product changes as well as to respond to questions related to registration.

How can my country use this data?1 Countries can use the vaccine purchase data in several different ways, such as to:

• Understand how the price of vaccines in their immunization schedule relate to other products on the market, or compare the prices paid by other countries in similar conditions (e.g. income, funding/procurement group, contract conditions) – for example: how much does seasonal flu vaccine cost in countries similar to mine?

• Identify other vaccines available from a given manufacturer – for example, what products are in the portfolio of a manufacturer of interest for my country?

• Understand other available products and presentations for each vaccine – for example, which BCG vaccine products are on the market?

• Develop budget estimates to inform new vaccine introduction product choices, planning and budgeting

Page 2: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 2

The 2018 data, provided in Section D for easy reference, is organized by vaccine, listing all reported manufacturers and vial sizes. Prices are indicated by procurement mechanism, income group and WHO region. Reference to UNICEF price information is included in Section B; PAHO Revolving Fund prices are reported in Section C.

Building on the list of products reported as purchased by countries, WHO is also leveraging other publicly available intelligence to publish a more complete list of vaccine products available for procurement – including non-prequalified-vaccines.2 This list is included in Section A.

The Vaccine Purchase data set (including past years’ data) can also be downloaded in Excel format from http://who.int/immunization/MI4A

Moving forward, understanding and monitoring the impact of market information use in countries will be an area of focus for WHO and its partners. This will be an important step to better adapt the information and related support provided to countries – particularly for self-procuring MICs. WHO encourages countries to share their experience on data use at [email protected]. WHO can also respond to any request or questions at this address.

Key messages to countries The data shared by countries allows MI4A to complete global analysis, providing key insights to understand availability and affordability issues. A Global Vaccine Market Report is published annually, offering global insights on vaccine markets.3 MI4A also develops vaccine-specific Global Market Studies.

Some important vaccine-specific messages are found below – particularly for self-procuring middle-income countries.

2 The list of vaccine products provides an overview of vaccine products available organized by vaccine type, manufacturer and commercial name. See Section A and Excel format available on the WHO website: https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module1/en/ 3 The most recent version of the Global Vaccine Market Report is available at: https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/en/

BCG VACCINES:

As of 2019, available global supply is more than twice the global demand, and this situation is likely to continue in the future. BCG vaccine is produced by over 20 manufacturers, which ensures a large supplier base. However, there are still risks that could lead to national stock-outs in the event of production issues from individual manufacturers. This is due to:

(i) the concentration of a large share of global supply in two manufacturers that are regulated by the same NRA, which, coupled with an unstable manufacturing process, can contribute to unexpected and sudden reduction in availability; and

(ii) many countries having only one product registered.

Vaccine product registration is an important factor affecting access to vaccines. Registering more than one product will help countries to avoid stock-outs in the case of market exit or supply shortage from the preferred manufacturer. Investments have been made to streamline regulatory procedures, encourage the use of reliance and mutual recognition among National Regulatory Authorities, set up regional regulatory networks, enhance the use of the Collaborative Procedure for Accelerated Registration of Prequalified Products, and develop guidelines on procedures for post-approval changes. Dialogue between manufacturers, countries and WHO on how to resolve registration challenges and related matters is ongoing. Ultimately, it is up to countries’ leadership to bring about change.

Page 3: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 3

DIPHTHERIA AND TETANUS (D&T)–CONTAINING VACCINES:

Sufficient vaccine supply is available for all countries to introduce the recommended life course of six doses of D&T–containing vaccines and to replace TT vaccine with Td. However, supply of acellular pertussis (aP)–containing vaccines remains limited. It is sufficient to support demand from countries where the product is already in use, but introduction in additional countries may lead to availability issues and require, under all circumstances, 12 to 18 months advance notice to the suppliers or procurement agency. This constraint – and WHO recommendations on pertussis4 – should be taken into account before considering switching from whole-cell pertussis (wP)–containing products.

Supply for whole-cell (wP)–containing vaccines remains sufficient to absorb any production issues or sudden increases in demand. Some vaccine combinations (DTwP-HepB, DTwP-Hib, TdaP-IPV, Td-IPV) are used in a very limited number of countries and may be at risk of discontinuation from the manufacturers. Countries procuring those combinations should make themselves aware of potential product alternatives.

HPV VACCINES:5

Supply is currently insufficient to meet demand. According to the latest analysis, constraints are expected to last until at least 2023/24, possibly leading to challenges for countries to access HPV vaccines.

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization recommended the implementation of specific vaccination strategies to address short-/mid-term supply constraints: i) all countries to temporarily pause implementation of boys, older age group (>15 years) and multi-age cohort (MAC) HPV vaccination strategies; and ii) to

4 WHO Pertussis Position Paper (Last update August 2015): “National programmes currently administering wP vaccination should continue to use wP vaccines for primary vaccination series. Surveillance and modelling data suggest that the use of aP vaccines may result in a resurgence of pertussis after a number of years and such resurgence may also lead to an increased risk of death in those too young to be vaccinated.” https://www.who.int/wer/2015/wer9035.pdf?ua=1

5 WHO Weekly Epidemiological Record (WER) Meeting of the Strategic Advisory Group of Experts on Immunization, October 2019: conclusions and recommendations: https://apps.who.int/iris/bitstream/handle/10665/329962/WER9447-eng-fre.pdf?ua=1

Replacement of TT with Td vaccine for dual protection

In June 2018, WHO and UNICEF issued a joint communiqué urging countries to replace tetanus toxoid (TT) vaccine with tetanus-diphtheria (Td) vaccine – in light of the growing number of diphtheria outbreaks.*

As of January 2020, UNICEF will no longer fund TT vaccine, nor provide procurement services for supply of TT vaccine. UNICEF will continue to support Td vaccine only, in support of maternal immunization programmes.

WHO confirms sufficient supply is available to meet increased global demand for Td vaccines and highlights minimal price differentials between TT and Td vaccines.

For countries self-procuring TT vaccine, it is expected that this vaccine will remain available on the global market. However, as a result of decreased demand through UNICEF and market evolution toward production of Td vaccine, the cost and delivery lead-time of TT vaccine may increase. Those countries who have not yet planned this replacement are strongly encouraged to do so as soon as possible.

To streamline the logistics and reduce the number of different products needed for various age groups, WHO has also reviewed the evidence supporting the use of Td vaccine in younger children (ages 4-7 years) and is actively working with manufacturers for an on-label indication.

Available guidance and further information are available upon request.

*https://www.who.int/immunization/diseases/tetanus/WHO_UNICEF_Joint_communique_on_TT_to_Td_Replacement_Final28June2018.pdf

Page 4: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 4

retain the benefits of MACs, countries could target girls who are 13-14 years old or in the equivalent school grade with two-dose vaccination. Countries choosing to target 9- or 10-year-old girls or the equivalent school grade, could adopt an extended interval of three to five years between the two doses.

WHO reiterates that, from a public health perspective, all three licensed HPV vaccines have excellent safety profiles and offer comparable immunogenicity, efficacy and effectiveness for the prevention of cervical cancer, which is caused mainly by HPV types 16 and 18.6 In view of current market conditions, careful consideration by countries of all available HPV products is critical to enhance sustainable access to vaccines.

MENINGOCOCCAL VACCINES:7

The meningococcal vaccine market is diverse and complex, with regional variations in serogroup distribution, significant use outside of routine immunization, and 29 marketed products targeting various combinations of the five serogroups (A, B, C, W, Y) in conjugated and polysaccharide forms. Countries – particularly MICs – are facing a number of challenges in access to these vaccines. In particular, discontinued production of polysaccharide vaccines has reduced country access, and constraints in supply are expected to continue in the future.

The available supply of conjugate MenACWY is insufficient to meet demand growth triggered by rising incidence of serogroups C and W and reduced availability of polysaccharide vaccines. Middle- and lower-income countries should carefully evaluate product availability before vaccine introduction or switching from one vaccine to another. Countries are encouraged to regularly

6 WHO HPV Vaccines Position Paper (Last update May 2017): https://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf?sequence=1 7 WHO Meningococcal Vaccines Position Paper (Last update November 2011): https://www.who.int/wer/2011/wer8647.pdf?ua=1 8 WHO Pneumococcal Conjugate Vaccines Position Paper (Last update February 2019): https://apps.who.int/iris/bitstream/handle/10665/310968/WER9408.pdf?ua=1 9 WHO Guidance Note on interchangeability of rotavirus vaccines: https://www.who.int/immunization/diseases/rotavirus/Rota_mixed_schedules_interchangeability.pdf

share their plans with WHO and engage in dialogue with manufacturers early in this process.

PNEUMOCOCCAL VACCINES:

The total global supply/demand balance for pneumococcal conjugate vaccine (PCV) is currently sufficient and is expected to improve with additional manufacturers’ entrance. However, country preferences for specific vaccine subtypes could affect the balance. WHO encourages countries to consider all relevant aspects (such as local epidemiology, cost-effectiveness, affordability, delivery platforms, vaccine management, market conditions, etc.) when selecting a vaccine product.

As a reminder, the most recent (2019) WHO position paper8 states that both PCV10 and PCV13 subtypes are comparable in terms of their impact against pneumonia.

Pneumococcal polysaccharide vaccine supply is vulnerable because of the dependence on a single large manufacturer that accounts for most supply outside of China. Reduction of supply from this manufacturer could result in access issues. Continued dialogue with WHO and the supplier is recommended.

ROTAVIRUS VACCINES:

With the large-scale introduction of rotavirus vaccines in the last decade, some countries have faced challenges in access to the vaccines, and sometimes in securing enough doses of the same product. There are currently four prequalified rotavirus vaccines. Three of these vaccines require a three-dose schedule while one product is administered in a two-dose schedule. WHO recently published a guidance note on the interchangeability of rotavirus vaccines9 to support implementation of rotavirus programmes when there are multiple vaccine products available.

Page 5: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 5

WHO recommends that the rotavirus vaccination series for each child be completed with the same product whenever feasible. However, if the product used for a prior dose is unavailable or unknown, the series should be completed with any available licensed product. The effectiveness of a complete series that contains more than one product is likely to be greater than an incomplete series with one product.

What is MI4A? WHO launched the Market Information for Access (MI4A) project in 2018 with the objectives to: • Enhance the understanding of global vaccine

demand, supply and pricing dynamics and identifying affordability and shortage risks;

• Convene all relevant global health partners to contribute to the development of policies, strategies and guidance to address the identified risks; and

• Strengthen national and regional capacity for improved access to vaccines supply – focusing in particular on improving availability of information and use of data in self-funding and self-procuring middle-income countries. Those countries are mostly excluded from international support and the majority do not have sufficient access to market information.

This project was launched to contribute to the achievement of Sustainable Development Goal 3.8 (universal health coverage target) by enhancing access to safe, effective, quality and affordable vaccines for all. MI4A is part of the broader WHO effort to ensure availability of Essential Medicines and responds to specific requests from Member States and SAGE to address vaccine market information gaps.

The importance of improving access to vaccines and medicines was once again raised by Member States at the 2019 World Health Assembly with the endorsement of the WHO Access Roadmap for Medicines, Vaccines and Other Health Products.10 A resolution11 on improving the transparency of markets for medicines, vaccines and other health products was also adopted to “facilitate efforts towards affordable and equitable access to health products.”

Building on the success of the Vaccine Product, Price and Procurement (V3P) project, WHO is already making great progress in improving the availability of vaccine price information with MI4A. WHO congratulates countries for sharing vaccine purchase data with each other to inform decision-making on new vaccine introduction and to enhance efficiency of procurement processes and planning and budgeting cycles.

More information on WHO’s MI4A initiative is available at: http://who.int/immunization/MI4A

10 WHO. (2018). Addressing the global shortage of, and access to, medicines and vaccines. http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_12-en.pdf 11 WHO. (2019). Improving the transparency of markets for medicines, vaccines, and other health products. http://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_ACONF2Rev1-en.pdf

Page 6: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 6

Disclaimer

Information contained in the MI4A database is provided by participating countries that have agreed to share vaccine price and procurement data. Participating countries are solely responsible for the accuracy of the data provided.

The information contained in the MI4A database does not in any way imply an endorsement, certification, warranty of fitness or recommendation by WHO of any company or product for any purpose, and does not imply preference over products of a similar nature that are not mentioned. WHO furthermore does not warrant that: (1) the information is complete and/or error free; and/or that (2) the products listed are of acceptable quality, have obtained regulatory approval in any country, or that their use is otherwise in accordance with the national laws and regulations of any country, including but not limited to patent laws. Inclusion of products in the database does not furthermore imply any approval by WHO of the products in question (which is the sole prerogative of national authorities).

WHO will not accept any liability or responsibility whatsoever for any injury, death, loss, damage, or other prejudice of any kind that may arise as a result of, or in connection with the procurement, distribution and use of any product listed in the MI4A database.

Page 7: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Vaccine WHO PQ Manufacturer Vial Size Commercial Name (where available)

Anthrax No Emergent Biosolutions 10-dose BioThrax

Ministry of Defense, Russia 10-dose Unknown

BCG No AJ Vaccines A/S 20-dose BCG vaccine (former SSI - Statens Serum Institut)

Biomed Lublin 10-dose Antitubercle vaccine (Szczepionka przeciwgruźlicza)

Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 5-dose Unknown

Fundacao Ataulpho de Paiva 10-dose BCG vaccine

GreenSignal Bio Pharma Limited 20-dose BCG vaccine (Freeze Dried) - Intradermal

Institut Pasteur de Tunis 20-dose BCG vaccine, freeze-dried - Pasteur 1173 P2 strain

Institut Pasteur Iran 20-dose Lyophilized B.C.G vaccine

Institute of Vaccines and MedicalBiologicals 10-dose Freeze dried BCG vaccine

Japan BCG Laboratory 1-dose Freeze-Dried BCG Vaccine for Percutaneous Use

Microgen 10-dose BCG. One dose contains 0.05mg of BCG cells in 0.1 ml of solvent

20-dose BCG. One dose contains 0.05mg of BCG cells in 0.1 ml of solvent

PT Bio Farma (Persero) 20-dose BCG Vaccine (Freeze Dried)

Serum Institute of India Pvt. Ltd. 10-dose BCG Vaccine

Shanghai Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 5-dose Unknown

Thai Red Cross 10-dose Freeze dried BCG vaccine 0.1 mL

Torlak 20-dose BCG Vaccine

Yes AJ Vaccines A/S 10-dose BCG Vaccine SSI

Bul Bio - National Center of Infectiousand Parasitic Diseases Ltd.

10-dose BCG Vaccine

20-dose BCG Vaccine

Japan BCG Laboratory 10-dose BCG Freeze Dried Glutamate vaccine

20-dose BCG Freeze Dried Glutamate vaccine

Serum Institute of India Pvt. Ltd. 20-dose BCG Vaccine

A. Available Products List - as known to WHOThe MI4A Products List provides a snapshot overview of vaccine products available for procurement – irrespective of their WHOprequalification status – as of November 2019.

This list reflects information reported by countries through the 2019 Joint Reporting Form (JRF) and is supplemented and amendedwith available information gathered through separate consultations. As part of the MI4A project, WHO conducts in-depth global marketstudies where the list of available vaccines can be considered comprehensive and up to date. Studies conducted so far include BCG,D&T-containing, meningococcal, HPV, and pneumococcal vaccines. For all the other vaccines it should be noted that this list may notbe complete and may be missing some products whose availability is not documented through public reported data and sources.

For reference the list of WHO Prequalified vaccines is available on the WHO website:https://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/

This list is also available for download in Excel format at the WHO/MI4A website: http://who.int/immunization/MI4A

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 7

Page 8: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

BCG YesJapan BCG Laboratory 20-dose BCG Freeze Dried Glutamate vaccine

Serum Institute of India Pvt. Ltd. 20-dose BCG Vaccine

bOPV No BIRMEX 20-dose Vacuna Antipoliomielítica Bivalente Oral

Chumakov Federal Scientific Center 10-dose Unknown

POLYVAC 20-dose Unknown

Razi Vaccine & Serum Research Institute 15-dose bOPV vaccine

Sanofi Pasteur 10-dose Unknown

Yes Beijing Institute of Biological ProductsCo., Ltd. (CNBG Subsidiary) 20-dose Poliomyelitis Vaccine (live, oral attenuated, human Diploid Cell),

type 1 and 3, 20 dose

Bharat Biotech International Limited 10-dose BIOPOLIO B1/3

20-dose BIOPOLIO B1/3

GlaxoSmithKline Biologicals SA 10-dose Polio Sabin One and Three

20-dose Polio Sabin One and Three

Haffkine Bio Pharmaceutical CorporationLtd 20-dose Bivalent type 1&3 Oral Poliomyelitis vaccine, IP (bOPV1&3)

Panacea Biotec Ltd. 20-dose Unknown

PT Bio Farma (Persero) 10-dose Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3)

20-dose Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3)

Sanofi Pasteur 20-dose Unknown

Serum Institute of India Pvt. Ltd. 10-dose Poliomyelitis Vaccine (Oral), Bivalent types 1 and 3

20-dose Poliomyelitis Vaccine (oral) Bivalent types 1 and 3

Dengue No Sanofi Pasteur 1-dose Dengvaxia

5-dose Dengvaxia

Diphtheria No IBSS Biomed 1-dose Unknown

20-dose Unknown

Microgen 2-dose AD-M toxoid - Diphtheria toxoid adsorbed purified with reducedantigen content liquid (ATC: J06AA01 Diphtheria toxoid) - 0.5 mL

DT No Biological E. Limited 1-dose Adsorbed Diphtheria and Tetanus Vaccine

10-dose Adsorbed Diphtheria and Tetanus Vaccine

20-dose Adsorbed Diphtheria and Tetanus Vaccine

Finlay Institute 1-dose VA-DIFTET

5-dose VA-DIFTET

10-dose VA-DIFTET

20-dose VA-DIFTET

IBSS Biomed 1-dose Unknown

Instituto Butantan Unknown Unknown

Microgen 2-dose DIPHTHERIA AND TETANUS ANATOXIN (TOXOID)

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 8

Page 9: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DT NoInstituto Butantan Unknown Unknown

Microgen 2-dose DIPHTHERIA AND TETANUS ANATOXIN (TOXOID)

Razi Vaccine & Serum Research Institute 14-dose DT vaccine

Sanofi Pasteur 1-dose DT VAX

10-dose DT VAX

Takeda Unknown ADSORBED DIPHTHERIA-TETANUS COMBINED TOXOID TAKEDA

Torlak 10-dose Ditevaksal-T (DT)

Vacsera Unknown Unknown

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 4-dose Unknown

Yes Bul Bio - National Center of Infectiousand Parasitic Diseases Ltd.

10-dose Diftet

20-dose Diftet

PT Bio Farma (Persero) 10-dose Adsorbed DT Vaccine

Serum Institute of India Pvt. Ltd. 1-dose Diphtheria and Tetanus Vaccine Adsorbed (Paediatric)

10-dose Diphtheria and Tetanus Vaccine Adsorbed (Ped)

20-dose Diphtheria and Tetanus Vaccine Adsorbed (Ped)

DTaP No Boryung 1-dose Boryung Purified PDT Vaccine

Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Unknown

GlaxoSmithKline Biologicals SA 1-dose Infanrix

Sanofi Pasteur 1-dose Tripacel

Walvax 1-dose Diptheria, Tetanus and Acellular Pertussis Combined Vaccine,Adsorbed

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Unknown

DTaP-HepB-Hib-IPV No GlaxoSmithKline Biologicals SA 1-dose Infanrix hexa

Merck Vaccines/Sanofi Pasteur vaccine 1-dose Vaxelis (5 component pertussis, Merck/Sanofi Pasteur)

Yes Sanofi Pasteur 1-dose Hexaxim (2 component pertussis)

DTaP-HepB-IPV No GlaxoSmithKline Biologicals SA 1-dose Infanrix Penta

DTaP-Hib No Beijing Minhai Biotec Group 1-dose DTaP-Hib Combined Vaccine

DTaP-Hib-IPV No AJ Vaccines A/S 1-dose DiTeKiPol/Hib

GlaxoSmithKline Biologicals SA 1-dose Infanrix-IPV/Hib

Sanofi Pasteur 1-dose Pentaxim, Pentavac (2 component pertussis), Pentacel (5component) or Pediacel (5 component)

DTaP-IPV No AJ Vaccines A/S 1-dose Unknown

Biken Co. Ltd. 1-dose Unknown

Daiichi Sankyo 1-dose Unknown

GlaxoSmithKline Biologicals SA 1-dose Kinrix (for use in children age 4-6 yrs old only)

KM Biologics Co. Ltd. 1-dose Unknown

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 9

Page 10: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTaP-IPV NoGlaxoSmithKline Biologicals SA 1-dose Kinrix (for use in children age 4-6 yrs old only)

KM Biologics Co. Ltd. 1-dose Unknown

Mitsubishi Tanabe Pharma 1-dose TETRABIK

Sanofi Pasteur 1-dose Tetravac (2 component pertussis), Tetraxim (2 component) orQuadracel (5 component)

DTwP No Bharat Biotech International Limited 1-dose ComVac 3

5-dose ComVac 3

10-dose ComVac 3

Finlay Institute 1-dose DTP-vax

5-dose DTP-vax

10-dose DTP-vax

20-dose DTP-vax

IBSS Biomed 1-dose DTP-Szczepionka bloniczo-tezcowo-krztuscowa adsorbowanaBiomed

Indian Immunologicals Ltd Unknown Abhay-TAG

1-dose Abhay-TAG

Institut Pasteur Iran 10-dose Unknown

Institute of Vaccines and MedicalBiologicals 20-dose DTP Vaccine 10mL/vial

Institute Rafael Rangel Caracas Unknown Unknown

Instituto Butantan Unknown Unknown

Microgen 2-dose DTP-vaccine

Panacea Biotec Ltd. 1-dose DTP vaccine

2-dose DTP vaccine

5-dose DTP vaccine

10-dose DTP vaccine

Razi Vaccine & Serum Research Institute Unknown DTP

Vacsera 1-dose DTP vaccine

10-dose DTP vaccine

Yes Biological E. Limited 1-dose TRIPVAC

10-dose TRIPVAC

PT Bio Farma (Persero) 10-dose DTP Vaccine

Serum Institute of India Pvt. Ltd. 1-dose Diphtheria-Tetanus-Pertussis Vaccine Adsorbed

10-dose Diphtheria-Tetanus-Pertussis Vaccine Adsorbed

20-dose Diphtheria-Tetanus-Pertussis Vaccine Adsorbed

DTwP-HepB No Bharat Biotech International Limited 1-dose ComVac4

1-dose Diphtheria, Tetanus, Pertussis (Whole Cell) and Hepatitis B(rDNA) Vaccine (Adsorbed)

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 10

Page 11: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTwP-HepB NoBharat Biotech International Limited 1-dose ComVac4

Biological E. Limited 1-dose Diphtheria, Tetanus, Pertussis (Whole Cell) and Hepatitis B(rDNA) Vaccine (Adsorbed)

10-dose Diphtheria, Tetanus, Pertussis (Whole Cell) and Hepatitis B(rDNA) Vaccine (Adsorbed)

Microgen 2-dose DTP-HepB

Yes Serum Institute of India Pvt. Ltd. 1-dose Diphtheria ,Tetanus, Pertussis and Hepatitis B Vaccine Adsorbed

10-dose Diphtheria ,Tetanus, Pertussis and Hepatitis B Vaccine Adsorbed

20-dose Diphtheria ,Tetanus, Pertussis and Hepatitis B Vaccine Adsorbed

DTwP-HepB-Hib No Arabio 1-dose AraPenta

Bharat Biotech International Limited 10-dose ComVac5

Centro de Ingenieria Genetica yBiotecnologia 1-dose Heberpenta-L

HLL Biotech Limited 1-dose PENTAHIL

Incepta vaccine 1-dose Propenta Vaccine

10-dose Propenta Vaccine

Indian Immunologicals Ltd 10-dose Vaxtar 5

Yes Biological E. Limited 1-dose ComBE Five

2-dose ComBE Five

5-dose ComBE Five

10-dose ComBE Five

Janssen Vaccines Corp. 1-dose Quinvaxem

LG Chem Ltd 1-dose Eupenta

10-dose Eupenta

Panacea Biotec Ltd. 1-dose Easyfive-TT

10-dose Easyfive-TT

PT Bio Farma (Persero) 5-dose Pentabio

10-dose Pentabio

Serum Institute of India Pvt. Ltd. 1-dose Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilusinfluenzae type b Conjugate Vaccine

2-dose Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilusinfluenzae type b Conjugate Vaccine

10-dose Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilusinfluenzae type b Conjugate Vaccine Adsorbed

Shantha Biotechnics Private Limited (ASanofi Company)

1-dose Shan-5

10-dose Shan-5

DTwP-HepB-Hib-IPV No Panacea Biotec Ltd. 1-dose Easysix

4-dose Easysix

DTwP-Hib No Bio-Manguinhos/Fiocruz 5-dose Diphtheria, tetanus, pertussis, and Haemophilus influenzae B(conjugated) Vaccine

10-dose Diphtheria, tetanus, pertussis, and Haemophilus influenzae B(conjugated) Vaccine

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 11

Page 12: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTwP-Hib No Bio-Manguinhos/Fiocruz5-dose

Diphtheria, tetanus, pertussis, and Haemophilus influenzae B(conjugated) Vaccine

10-dose Diphtheria, tetanus, pertussis, and Haemophilus influenzae B(conjugated) Vaccine

Panacea Biotec Ltd. 1-dose Easyfour-TT

Yes Serum Institute of India Pvt. Ltd. 1-dose Diphtheria-Tetanus-Pertussis (whole cell)-Haemophilus influenzaetype b freeze-dried

Ebola Yes Merck Vaccines 1-dose ERVEBO

HepA (adult) No Changchun Institute of BiologicalProducts Co.,Ltd (CNBG Subsidiary) 1-dose Unknown

Chinese Academy of Medical SciencesInstitute of Medical Biology 1-dose Unknown

Merck Vaccines 1-dose VAQTA, Hepatitis A Vaccine Inactivated - 1mL

Sanofi Pasteur 1-dose Avaxim 160 U Adult

Vector-BiAlgam 1-dose Hepatitis A

Yes GlaxoSmithKline Biologicals SA 1-dose Havrix 1440 Adult

Sinovac Biotech Co. Ltd 1-dose Healive

HepA (ped.) No Convac 1-dose Unknown

Instituto Butantan 1-dose Vacina adsorvida hepatite A (inativada)

Merck Vaccines 1-dose VAQTA, Hepatitis A Vaccine Inactivated - 0.5mL

Sanofi Pasteur 1-dose Avaxim 80 U Pediatric

Vector-BiAlgam 1-dose Hepatitis A

Zhejiang Pukang Biology 1-dose MEVAC-A

Yes GlaxoSmithKline Biologicals SA 1-dose Havrix 720 Junior

Sinovac Biotech Co. Ltd 1-dose Healive - 0.5ml containing 250u

HepA-Typhoid No GlaxoSmithKline Biologicals SA 1-dose HepaTyrix

HepA+B No GlaxoSmithKline Biologicals SA 1-dose Twinrix

HepB (adult) No Binnopharm 1-dose Regevac B

BioKantai 1-dose Unknown

Centro de Ingenieria Genetica yBiotecnologia

1-dose Heberbiovac HB

5-dose Heberbiovac HB

Dalian Hissen 1-dose Unknown

GlaxoSmithKline Biologicals SA 1-dose Engerix B 20mcg

Hualan Biological Bacterin Co., Ltd Unknown Unknown

Janssen Vaccines Corp. 1-dose Hepavax-Gene TF (thimerosal free)

LG Chem Ltd 1-dose Euvax B (adult)

10-dose Euvax B (adult)

Merck Vaccines 1-dose HB Vaxpro

North China Pharmaceutical Group Unknown Unknown

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 12

Page 13: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepB (adult) NoMerck Vaccines 1-dose HB Vaxpro

North China Pharmaceutical Group Unknown Unknown

Yes PT Bio Farma (Persero) 1-dose Hepatitis B Vaccine Recombinant

Serum Institute of India Pvt. Ltd. 1-dose Hepatitis B Vaccine (rDNA) (Adult)

10-dose Hepatitis B Vaccine (rDNA) (Adult)

HepB (ped.) No BioKantai 1-dose Unknown

Dalian Hissen 1-dose Unknown

Hualan Biological Bacterin Co., Ltd Unknown Unknown

Institut Pasteur Iran 10-dose Recombinant hepatitis B vaccine

Instituto Butantan 10-dose Vacina adsorvida hepatite B (recombinante)

Janssen Vaccines Corp. 1-dose Hepavax

Merck Vaccines 1-dose HB Vaxpro

North China Pharmaceutical Group Unknown Unknown

VABIOTECH 1-dose Hepatitis B vaccine 0.5 ml

Yes Centro de Ingenieria Genetica yBiotecnologia

1-dose Heberbiovac HB

10-dose Heberbiovac HB

GlaxoSmithKline Biologicals SA 1-dose Engerix

10-dose Engerix

20-dose Engerix

LG Chem Ltd 2-dose Euvax B

10-dose Euvax B

Serum Institute of India Pvt. Ltd. 1-dose Hepatitis B Vaccine (rDNA) (Ped)

10-dose Hepatitis B Vaccine (rDNA) (Ped)

Hib No Beijing Minhai Biotec Group Unknown Unknown

Chongqing Zhifei Biological Products CoLtd Unknown Unknown

GlaxoSmithKline Biologicals SA 1-dose Hiberix

Lanzhou Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

LG Chem Ltd 1-dose Euhib

Merck Vaccines 1-dose Pedvax HIB

Olymvax Biopharmaceuticals Unknown Unknown

Walvax Unknown Unknown

Yes Centro de Ingenieria Genetica yBiotecnologia Unknown Quimi-Hib

Sanofi Pasteur 1-dose Act-HIB

Serum Institute of India Pvt. Ltd. 1-dose Hemophilus influenzae type b Conjugated Vaccine

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 13

Page 14: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Hib YesSanofi Pasteur 1-dose Act-HIB

Serum Institute of India Pvt. Ltd. 1-dose Hemophilus influenzae type b Conjugated Vaccine

Hib-MenC conj. No GlaxoSmithKline Biologicals SA 1-dose Menitorix

HPV2 Yes GlaxoSmithKline Biologicals SA 1-dose Cervarix

2-dose Cervarix

HPV4 Yes Merck Vaccines 1-dose Gardasil

HPV9 Yes Merck Vaccines 1-dose Gardasil 9

IPV No Beijing Institute of Biological ProductsCo., Ltd. (CNBG Subsidiary) Unknown Unknown

Bio-Manguinhos/Fiocruz 10-dose Poliomyelitis 1, 2 and 3 (inactivated)

Chinese Academy of Medical SciencesInstitute of Medical Biology Unknown Unknown

Korea Vaccine 1-dose Kovax Polio PF Inj

Sanofi Pasteur 1-dose IMOVAX POLIO

Yes AJ Vaccines A/S 1-dose IPV vaccine SSI

Bilthoven Biologicals 1-dose Poliomyelitis vaccine

5-dose Poliomyelitis vaccine multidose, suspension for injection 2.5 mL

GlaxoSmithKline Biologicals SA 1-dose Poliorix

2-dose Poliorix

Sanofi Pasteur 10-dose IMOVAX POLIO

Serum Institute of India Pvt. Ltd. 1-dose Poliomyelitis Vaccine (Inactivated)

2-dose Poliomyelitis Vaccine (Inactivated)

5-dose Poliomyelitis Vaccine (Inactivated)

10-dose Poliomyelitis Vaccine (Inactivated)

Shantha Biotechnics Private Limited (ASanofi Company) 5-dose ShanIPV

JE inactivated (ped.)No Boryung 1-dose Boryung Cell culture-derived Japanese Encephalitis Vaccine(injection)

Cheng Da Biotechnology Unknown Unknown

VABIOTECH 10-dose Japanese Encephalitis vaccine - tech transfer from BIKENInstitute,Japan 5mL

Valneva 1-dose Ixiaro

JE live attenuated(adult)

No Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

Yes Biological E. Limited 1-dose JEEV

5-dose JEEV

JE live attenuated(ped.)

No Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

GPO-MBP Co., Ltd. 1-dose IMOJEV MD

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary)

Unknown Unknown

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 14

Page 15: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

JE live attenuated(ped.)

NoGPO-MBP Co., Ltd. 1-dose IMOJEV MDWuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

Yes Biological E. Limited 1-dose JEEV

5-dose JEEV

Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary)

1-dose Japanese Encephalitis Vaccine Live (SA14-14-2)

5-dose Japanese Encephalitis Vaccine Live (SA14-14-2)

GPO-MBP Co., Ltd. 4-dose IMOJEV MD

Measles No Microgen 1-dose Measles vaccine

POLYVAC 10-dose Measles vaccine. Freeze-dried, live attenuated vaccine. AIK-CStrain 5mL

Yes PT Bio Farma (Persero) 10-dose Measles vaccine

20-dose Measles vaccine

Serum Institute of India Pvt. Ltd. 1-dose Measles Vaccine, Live attenuated

2-dose Measles Vaccine, Live attenuated

5-dose Measles Vaccine, Live attenuated

10-dose Measles Vaccine, Live attenuated

MenA conj. Yes Serum Institute of India Pvt. Ltd. 10-dose MenAfriVac A Conjugate Vaccine (5mcg)

MenAfriVac A Conjugate Vaccine (10mcg)

MenA Ps No Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

MenAC conj. No Chongqing Zhifei Biological Products CoLtd 1-dose MeningACon

Royal (Wuxi) Bio-Pharmaceutical Unknown Unknown

Walvax 1-dose Group A and C Meningococcal Conjugate Vaccine

MenAC Ps No Bio-Manguinhos/Fiocruz 10-dose Unknown

Bio-Med 1-dose Unknown

Finlay Institute 1-dose VaxMenAc

Hualan Biological Bacterin Co., Ltd Unknown Unknown

Lanzhou Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary)

Unknown Unknown

1-dose Unknown

Vacsera 1-dose Mencevax

Walvax Unknown Unknown

1-dose Unknown

MenAC+Hib conj. No Chongqing Zhifei Biological Products CoLtd 1-dose HibACon

MenACW-135 Ps No Finlay Institute 10-dose Vax-Men-ACW135

MenACYW-135 conj. No Arabio 1-dose Aramen : Conjugated Meningitis ACWY Vaccine (tech transfer)

GlaxoSmithKline Biologicals SA 1-dose Menveo

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 15

Page 16: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

MenACYW-135 conj.No Arabio 1-dose Aramen : Conjugated Meningitis ACWY Vaccine (tech transfer)

Yes GlaxoSmithKline Biologicals SA 1-dose Menveo

Pfizer 1-dose Nimenrix

Sanofi Pasteur 1-dose Menactra

MenACYW-135 Ps No Bio-Med 1-dose Quadri Meningo

Chengdu Kanghua Unknown Unknown

Chongqing Zhifei Biological Products CoLtd 1-dose Menwayc

Hualan Biological Bacterin Co., Ltd 1-dose Unknown

Incepta vaccine 1-dose Ingovax ACWY

Walvax 1-dose Unknown

MenB No GlaxoSmithKline Biologicals SA 1-dose Bexsero (ex Novartis product)

Pfizer 1-dose Trumenba

MenBC No Finlay Institute 1-dose VA-MENGOC-BC

MenC conj. No Ezequiel Dias Foundation (FUNED) 1-dose MenC vaccine (tech transfer)

GlaxoSmithKline Biologicals SA 1-dose Menjugate (ex Novartis product)

Pfizer 1-dose NeisVac-C (ex-Baxter product)

MM No Microgen 1-dose Mumps-Measles vaccine

Shanghai Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

MMR No Beijing Institute of Biological ProductsCo., Ltd. (CNBG Subsidiary) Unknown Unknown

Bio-Manguinhos/Fiocruz 10-dose Measles, Mumps, and Rubella

Razi Vaccine & Serum Research Institute 5-dose MMR

Shanghai Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

Yes GlaxoSmithKline Biologicals SA 1-dose Priorix

2-dose Priorix

Merck Vaccines 1-dose rHA M-M-R II

Serum Institute of India Pvt. Ltd. 1-dose Measles,Mumps and Rubella Vaccine Live attenuated

2-dose Measles,Mumps and Rubella Vaccine Live attenuated

5-dose Measles,Mumps and Rubella Vaccine Live attenuated

10-dose Measles,Mumps and Rubella Vaccine Live attenuated

MMRV No GlaxoSmithKline Biologicals SA 1-dose Priorix-Tetra

Merck Vaccines 1-dose ProQuad

mOPV1 Yes GlaxoSmithKline Biologicals SA 10-dose Polio Sabin Mono T1

20-dose Polio Sabin Mono T1

Haffkine Bio Pharmaceutical CorporationLtd

20-dose Oral Poliomyelitis vaccine, IP (mOPV1)

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 16

Page 17: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

mOPV1 YesGlaxoSmithKline Biologicals SA 20-dose Polio Sabin Mono T1Haffkine Bio Pharmaceutical CorporationLtd 20-dose Oral Poliomyelitis vaccine, IP (mOPV1)

PT Bio Farma (Persero) 20-dose Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)

Sanofi Pasteur 20-dose ORAL MONOVALENT TYPE 1 POLIOMYELITIS VACCINE

mOPV2 No PT Bio Farma (Persero) 20-dose Monovalent Oral Poliomyelitis Vaccine Type 2

Yes GlaxoSmithKline Biologicals SA 10-dose Polio Sabin Mono Two (oral)

20-dose Polio Sabin Mono Two (oral)

Sanofi Pasteur 20-dose ORAL MONOVALENT TYPE 2 POLIOMYELITIS VACCINE (mOPV2)

mOPV3 Yes GlaxoSmithKline Biologicals SA 10-dose Polio Sabin Mono Three (oral)

20-dose Polio Sabin Mono Three (oral)

Sanofi Pasteur 20-dose ORAL MONOVALENT TYPE 3 POLIOMYELITIS VACCINE

MR No Beijing Institute of Biological ProductsCo., Ltd. (CNBG Subsidiary) Unknown Unknown

Beijing Minhai Biotec Group Unknown Unknown

POLYVAC 10-dose MRVAC

Razi Vaccine & Serum Research Institute 10-dose MR

Yes Biological E. Limited 1-dose MRBEV

5-dose MRBEV

10-dose MRBEV

Serum Institute of India Pvt. Ltd. 1-dose Measles and Rubella Vaccine, Live, Attenuated

2-dose Measles and Rubella Vaccine, Live, Attenuated

5-dose Measles and Rubella Vaccine, Live, Attenuated

10-dose Measles and Rubella Virus Vaccine Live

Mumps No Microgen 1-dose Live tissue culture mumps vaccine

Sinovac Biotech Co. Ltd Unknown Unknown

Zhejiang Weixin Unknown Unknown

OCV No PaxVax 1-dose Vaxchora

Shanghai United Cell Biotechnology Unknown Unknown

VABIOTECH 1-dose mORCVax

Yes EuBiologics Co., Ltd. 1-dose Euvichol

Euvichol-plus

Shantha Biotechnics Private Limited (ASanofi Company) 1-dose Shanchol

Valneva 1-dose Dukoral

PCV10 Yes GlaxoSmithKline Biologicals SA 1-dose Synflorix

2-dose Synflorix

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 17

Page 18: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

PCV10 Yes GlaxoSmithKline Biologicals SA1-dose Synflorix

2-dose Synflorix

4-dose Synflorix

PCV13 Yes Pfizer 1-dose Prevnar 13

4-dose Prevnar 13 Multidose Vial

PPSV23 No Beijing Minhai Biotec Group 1-dose Unknown

Chengdu Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Unknown

Merck Vaccines 1-dose Pneumovax 23

Walvax 1-dose 23-valent Pneumococcal Polysaccharide Vaccine

Rabies No Bharat Biotech International Limited 1-dose Indirab

Changchun BCHT Unknown Unknown

Changchun Wes-bio Unknown Unknown

Changchun Zuoyi Unknown Unknown

Cheng Da Biotechnology Unknown Unknown

Chengdu Kanghua Unknown Unknown

Chumakov Federal Scientific Center 1-dose Rabies Vaccine

Guanzhou Connaught Unknown Unknown

Indian Immunologicals Ltd 1-dose AbhayRab

Instituto Butantan 1-dose inactivated rabies vaccine (VR/VERO)

Microgen 1-dose Inactivated concentrated tissue culture purified rabies vaccine

Rongan Biological Unknown Unknown

Shanghai Fosun Unknown Unknown

Shichuan Yuanda Unknown Unknown

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

ZhongKe Biopharm Co. Unknown Unknown

Yes Cadila Health Care LTD 1-dose VaxiRab N

Chiron Behring Vaccines Private Ltd. 1-dose Rabipur

Sanofi Pasteur 1-dose VERORAB

Serum Institute of India Pvt. Ltd. 1-dose Rabies Vaccine Inactivated (Freeze Dried) (RABIVAX-5)

Rota No Lanzhou Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Lanzhou Lamb Rotavirus

POLYVAC 1-dose Unknown

Yes Bharat Biotech International Limited 5-dose Rotavac

10-dose Rotavac

1-dose Rotarix

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 18

Page 19: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Rota YesBharat Biotech International Limited 10-dose Rotavac

GlaxoSmithKline Biologicals SA 1-dose Rotarix

5-dose Rotarix

Merck Vaccines 1-dose Rotateq

Serum Institute of India Pvt. Ltd. 1-dose ROTASIIL

2-dose ROTASIIL

Rubella No Microgen 1-dose Rubella Vaccine, Live, Attenuated

Yes Serum Institute of India Pvt. Ltd. 1-dose Rubella vaccine

2-dose Rubella Vaccine, Live, Attenuated

5-dose Rubella Vaccine, Live, Attenuated

10-dose Rubella Vaccine, Live, Attenuated

Seasonal Influenza(adult)

No Abbott Biologicals BV 1-dose Influvac

Adimmune Unknown AdimFlu-S

Boryung 1-dose Inflexal V, Aggripal S1, Surface Antigen of Influenza, Flu Vaccine

Changchun Institute of BiologicalProducts Co.,Ltd (CNBG Subsidiary) Unknown Unknown

GlaxoSmithKline Biologicals SA 1-dose Fluarix, Flulaval

GPO-MBP Co., Ltd. 4-dose Unknown

Instituto Butantan 10-dose Unknown

Korea Vaccine 1-dose Kovax Flu tetra, Kovax Influ tetra, Kovax - flu, Kovax - Influ,Influ- Kovax

Microgen 1-dose Unknown

Petrovax 1-dose Unknown

Seqirus Limited 1-dose Agrippal

Fluad

Flucelvax Quadrivalent

Shanghai Fosun Unknown Unknown

Sinovac Biotech Co. Ltd Unknown ANFLU; PANFLU

Yes Abbott Biologicals BV 1-dose Serinflu trivalent

Green Cross Corporation 1-dose GC FLU trivalent, GC FLU quadrivalent

10-dose GC FLU Multi inj. trivalent, GC FLU quadrivalent

Hualan Biological Bacterin Co., Ltd 1-dose Hualan flu trivalent

IL-YANG PHARMACEUTICAL CO., LTD. 1-dose ILYANG FLU trivalent

Sanofi Pasteur 1-dose Fluzone, Fluzone Quadrivalent

10-dose Fluzone, Fluzone Quadrivalent

Vaxigrip trivalent

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 19

Page 20: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Seasonal Influenza(adult)

Yes Sanofi Pasteur 10-doseFluzone, Fluzone Quadrivalent

Vaxigrip trivalent

Seqirus Limited 10-dose Afluria Quadrivalent

Agriflu trivalent

Fluvirin trivalent

Serum Institute of India Pvt. Ltd. 1-dose Nasovac-S Influenza Vaccine, Live, Attenuated (Human), trivalent

SK Bioscience Co., Ltd. 1-dose SKY Cellflu, SKY Cellflu Qaudrivalent

10-dose SKY Cellflu, SKY Cellflu Qaudrivalent

Seasonal Influenza(pedatric)

No Abbott Biologicals BV 1-dose Influvac

Adimmune Unknown AdimFlu-S

AstraZeneca 1-dose FluMist, FluMist QIV

Boryung 1-dose Inflexal V, Aggripal S1, Surface Antigen of Influenza, Flu Vaccine

Changchun Institute of BiologicalProducts Co.,Ltd (CNBG Subsidiary) Unknown Unknown

Korea Vaccine 1-dose Kovax Flu tetra, Kovax Influ tetra, Kovax - flu, Kovax - Influ,Influ- Kovax

Microgen 1-dose Unknown

Seqirus Limited 1-dose Afluria, Afluria Quadrivalent, FLUAD, Fluad pediatric, Agrippal,Flucelvax Quadrivalent

Shanghai Fosun Unknown Unknown

Sinovac Biotech Co. Ltd Unknown ANFLU; PANFLU

SK Bioscience Co., Ltd. 1-dose SKY Cellflu, SKY Cellflu Qaudrivalent

Yes Green Cross Corporation 1-dose GC FLU

10-dose GCFLU Multi inj.

Sanofi Pasteur 1-dose Fluzone, Fluzone Quadrivalent

10-dose Vaxigrip

TBE (adult) No Bavarian Nordic 1-dose Encepur

Changchun Institute of BiologicalProducts Co.,Ltd (CNBG Subsidiary) Unknown Unknown

Chumakov Federal Scientific Center 1-dose Unknown

Microgen 1-dose EnceVir

Pfizer 1-dose TicoVac (0.5ml) (ex-Baxter product)

TBE (ped.) No Bavarian Nordic 1-dose Encepur

Chumakov Federal Scientific Center 1-dose Unknown

Microgen 1-dose EnceVir

Pfizer 1-dose Ticovac Junior (0.25ml) (ex-Baxter product)

TCV Yes Bharat Biotech International Limited 1-dose Typbar-TCV

5-dose Typbar-TCV

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 20

Page 21: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

TCV Yes Bharat Biotech International Limited1-dose Typbar-TCV

5-dose Typbar-TCV

Td No AJ Vaccines A/S 1-dose diTeBooster (0.5 ml) (former SSI - Statens Serum Institut)

Bul Bio - National Center of Infectiousand Parasitic Diseases Ltd. 1-dose Tetadif

Finlay Institute 10-dose diTe-Vax

IBSS Biomed 1-dose Clodivac

Intervax 10-dose Td

MassBiologics 1-dose Td

Microgen 2-dose DIPHTHERIA AND TETANUS ANATOXIN (TOXOID), REDUCEDANTIGEN CONTENT

Razi Vaccine & Serum Research Institute 10-dose Td vaccine

Sanofi Pasteur 1-dose IMOVAX dT adult

Torlak 10-dose Ditevaksal-T (Td)

Yes Biological E. Limited 1-dose BE Td

10-dose BE Td

Bul Bio - National Center of Infectiousand Parasitic Diseases Ltd.

10-dose Tetadif

20-dose Tetadif

PT Bio Farma (Persero) 10-dose Unknown

Sanofi Pasteur 10-dose IMOVAX dT adult

Serum Institute of India Pvt. Ltd. 1-dose Diphtheria and Tetanus Vaccine Adsorbed for Adults andAdolescents

10-dose Diphtheria and Tetanus Vaccine Adsorbed for AdultsandAdolescents

20-dose Diphtheria and Tetanus Vaccine Adsorbed for AdultsandAdolescents

Td-IPV No Bilthoven Biologicals 5-dose DTP Vaccin

Sanofi Pasteur 1-dose Dultavax, Revaxis

Tdap No AJ Vaccines A/S 1-dose TdapBooster

Instituto Butantan 1-dose Tdap, in partnership with GSK

Yes GlaxoSmithKline Biologicals SA 1-dose Boostrix

Sanofi Pasteur 1-dose Adacel, Covaxis, Trivaxis

Tdap-IPV No AJ Vaccines A/S 1-dose Unknown

GlaxoSmithKline Biologicals SA 1-dose Boostrix-Polio

Sanofi Pasteur 1-dose Adacel-Polio, Repevax

TT No IBSS Biomed 1-dose Tetana (0.5 ml)

Institute of Vaccines and MedicalBiologicals 20-dose TT vaccine 10ml/vial

Intervax 10-dose Tetanus Toxoid Vaccine Adsorbed

20-dose Tetanus Toxoid Vaccine Adsorbed

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 21

Page 22: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

TT No Intervax10-dose Tetanus Toxoid Vaccine Adsorbed

20-dose Tetanus Toxoid Vaccine Adsorbed

Microgen 2-dose TETANUS ANATOXIN (TOXOID)

Olymvax Biopharmaceuticals Unknown Unknown

Sanofi Pasteur 1-dose Imovax tetano

Torlak 1-dose Tetavaksal-T

Wuhan Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) Unknown Unknown

Yes Biological E. Limited 1-dose BEtt

10-dose BEtt

20-dose BEtt

Bul Bio - National Center of Infectiousand Parasitic Diseases Ltd.

10-dose Tetatox

20-dose Tetatox

PT Bio Farma (Persero) 1-dose TT vaccine

10-dose TT vaccine

20-dose TT vaccine

Sanofi Pasteur 10-dose TETAVAX

20-dose TETAVAX

Serum Institute of India Pvt. Ltd. 1-dose Tetanus Toxoid Vaccine Adsorbed

10-dose Tetanus Toxoid Vaccine Adsorbed

20-dose Tetanus Toxoid Vaccine Adsorbed

Shantha Biotechnics Private Limited (ASanofi Company)

10-dose ShanTT

20-dose ShanTT

Typhoid Ps No Boryung 1-dose Zerotyph Cap.

GlaxoSmithKline Biologicals SA 1-dose Typherix

IBSS Biomed 20-dose Ty -typhoid vaccine

PaxVax 1-dose Vivotif (ex-Crucell vaccine)

Sanofi Pasteur 1-dose Typhym-Vi

Yes Sanofi Pasteur 20-dose Typhym-Vi

Typhoid-Tetanus No IBSS Biomed 20-dose TyT Typhoid and tetanus vaccine

Varicella No Changchun BCHT 1-dose Unknown

Changchun Keygen Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Unknown

GlaxoSmithKline Biologicals SA 1-dose Varilrix

Green Cross Corporation 1-dose Varicella Vaccine-GCC inj.

Shanghai Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary)

1-dose Unknown

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 22

Page 23: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Varicella NoGreen Cross Corporation 1-dose Varicella Vaccine-GCC inj.Shanghai Institute of Biological ProductsCo.,Ltd (CNBG Subsidiary) 1-dose Unknown

Shanghai Rongsheng Biotech 1-dose Unknown

SK Bioscience Co., Ltd. 1-dose SKY Varicella Inj.

Yes Merck Vaccines 1-dose Varivax

YF Yes Bio-Manguinhos/Fiocruz 5-dose Yellow Fever

10-dose Yellow Fever

50-dose Yellow Fever

Chumakov Federal Scientific Center 2-dose YELLOW FEVER VACCINE LIVE FREEZE-DRIED

5-dose YELLOW FEVER VACCINE LIVE FREEZE-DRIED

10-dose YELLOW FEVER VACCINE LIVE FREEZE-DRIED

Institut Pasteur de Dakar 5-dose Stabilized Yellow Fever Vaccine

10-dose Stabilized Yellow Fever Vaccine

20-dose Stabilized Yellow Fever Vaccine

Sanofi Pasteur 10-dose STAMARIL

Zoster No GlaxoSmithKline Biologicals SA 1-dose Shingrix

Merck Vaccines 1-dose Zostavax

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 23

Page 24: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

B. UNICEF Vaccine Prices

UNICEF publishes historic, current and future awarded prices for vaccines, following consultations with vaccine suppliers

to UNICEF on making pricing information more transparent.

Vaccine Price Data is available at: https://www.unicef.org/supply/index_57476

Vaccine market notes are available at: https://www.unicef.org/supply/index_54214

Historical procurement data are available at: https://www.unicef.org/supply/index_102225

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 24

Page 25: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Vaccine Vial Size Comments 2018 2019BCG 10-dosebOPV 10-dose

20-doseDT 10-doseDTaP 1-doseDTaP-HepB-Hib-IPV 1-doseDTaP-Hib-IPV 1-doseDTaP-IPV 1-doseDTwP 10-doseDTwP-HepB-Hib 1-doseDTwP-Hib 1-doseHepA (adult) 1-doseHepA (ped.) 1-doseHepB (adult) 1-dose

10-doseHepB (ped.) 1-doseHib 1-doseHPV2 1-doseHPV4 1-doseIPV 1-dose

5-doseMenACYW conj. 1-doseMMR 1-dose Jeryl-Lynn

Zagreb5-dose Zagreb

MR 1-dose10-dose

OCV 1-dosePCV10 1-dosePCV13 1-dosePPSV23 1-doseRabies 1-doseRota 1-doseSeasonal Influenza(adult)

1-dose QuadrivalentQuadrivalent, France OriginQuadrivalent, Korea OriginTrivalent, France OriginTrivalent, Korea Origin

10-dose Quadrivalent, France OriginQuadrivalent, Korea OriginTrivalent, France OriginTrivalent, Korea Origin

Seasonal Influenza(Ped.)

20-dose QuadrivalentTrivalent, France OriginTrivalent, Korea Origin

Td 10-doseTdap 1-doseTyphoid Ps 20-doseVaricella 1-doseYF 5-dose

10-dose

$0.22$0.21$0.17$0.17$0.13$0.13

$0.17 $0.16$15.00$15.00$21.12$20.60$14.80$14.20$12.00$11.50$0.18$0.17$1.09$1.08$2.65$2.65$13.28$13.20$8.14$8.12$0.33$0.33$0.24$0.18$0.22$0.22$2.05$2.05

$8.50$9.58

$5.50$5.30$3.10$2.00$20.30$20.30$5.59$5.59$2.75$2.75$1.43$1.43$2.48$2.25$0.66$0.62

$1.85 $1.70$12.85$12.85$14.50$14.50$8.30$7.98

$13.00$12.80 $9.00$6.50$6.50

$6.00$6.00

$5.40$4.50

$4.24$3.50

$3.29$5.14$4.40

$3.59$2.65$2.65$2.44$2.19$2.15

$2.57$1.33$1.33$1.10$1.08$0.10$0.09$12.72$11.47$10.00$9.00$16.59$14.46

$1.28$1.43$1.43

C. PAHO Revolving Fund (RF) Public Weighted Average PricePAHO RF's vaccine weighted average prices for current and previous years are available at:https://www.paho.org/hq/index.php?option=com_content&view=article&id=1864:paho-revolving-fund&Itemid=4135&lang=en

-

--

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 25

Page 26: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Vaccine Vial Size ManufacturerProcurementMechanism Commercial Name Region Country Alias

BCG 10-dose AJ Vaccine Other BCG Vaccine SSI AMRO UMIC1010

Self-procurement BCG Vaccine SSI EURO HIC1008

WPRO HIC1153

Biomed Lublin Self-procurement Antitubercle vaccine (Szczepionkaprzeciwgruźlicza)

EURO UMIC1077

HIC1165

HIC1096

HIC1088

HIC1155

HIC1003

Bul Bio - NCIPD Self-procurement BCG Vaccine EURO UMIC1087

UMIC1147

Fundacao Ataulphode Paiva Self-procurement BCG vaccine AMRO UMIC1042

Institute of Vaccinesand MedicalBiologicals, Vietnam

Self-procurement Freeze dried BCG vaccine WPRO LMIC1018

Japan BCGLaboratory

Self-procurement BCG Freeze Dried Glutamate vaccineAMRO UMIC1116

WPRO HIC1061

Microgen Self-procurement BCG. One dose contains 0.05mg ofBCG cells in 0.1 ml of solvent EURO UMIC1112

Serum Institute ofIndia

Self-procurement BCG Vaccine AFRO UMIC1084

EMRO HIC1098

$0.17

$29.36

$6.85

$1.14

$0.92

$1.10

$0.95

$2.09

$1.76

$0.10

$0.53

$0.42

$0.06

$1.16

$0.89

$0.09

$0.20

D. Country-reported PricesNotes:

Excludes purchases made via UNICEF SD or PAHO RF as countries paid the prices listed in sections B and C.

Only shows 2018 purchases where price was reported.

Excludes vaccines that had purchases reported by fewer than 4 countries.

Commercial name is a field derived based on the product information reported by countries. The purpose of this field is to provide additional detail on the product purchased and may not match the brand name of the product in the purchasing country as brand names for the same product may vary between countries.

Price per dose

-

-

-

-

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 26

Page 27: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

BCG 10-dose Serum Institute ofIndia

Self-procurement BCG VaccineAFRO UMIC1084

EMRO HIC1098

EURO HIC1137

SEARO LMIC1072

Thai Red Cross Self-procurement Freeze dried BCG vaccine 0.1 mL SEARO UMIC1074

20-dose AJ Vaccine Self-procurement BCG vaccine (former SSI - StatensSerum Institut)

AFRO UMIC1067

WPRO HIC1109

GreenSignal BioPharma Limited

Self-procurement BCG vaccine (Freeze Dried) -Intradermal

AFRO UMIC1067

SEARO LMIC1072

Institut Pasteur deTunis Self-procurement BCG vaccine, freeze-dried - Pasteur1173 P2 strain EMRO LMIC1043

Institut Pasteur Iran Self-procurement Lyophilized B.C.G vaccine EMRO UMIC1119

Japan BCGLaboratory

Self-procurement BCG Freeze Dried Glutamate vaccineEMRO HIC1171

HIC1106

EURO UMIC1176

WPRO UMIC1051

Microgen Self-procurement BCG. One dose contains 0.05mg ofBCG cells in 0.1 ml of solvent

EURO UMIC1112

UMIC1188

PT Bio Farma(Persero) Other BCG Vaccine (Freeze Dried) SEARO LMIC1047

Serum Institute ofIndia

Other BCG Vaccine AMRO UMIC1133

Self-procurement BCG Vaccine AFRO LIC1041

UMIC1104

UMIC1175

UMIC1067

LMIC1142

$0.20

$1.29

$0.06

$0.40

$0.16

$1.02

$0.19

$0.06

$0.17

$0.28

$0.45

$0.25

$0.28

$0.64

$0.06

$0.05

$0.22

$0.14

$0.14

$0.19

$0.34

$0.11

$0.35

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 27

Page 28: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

BCG 20-dose Serum Institute ofIndia

Self-procurement BCG Vaccine AFROUMIC1067

LMIC1142

UMIC1186

HIC1144

EMRO LMIC1066

UMIC1139

HIC1007

SEARO LMIC1150

Torlak Self-procurement BCG Vaccine EURO UMIC1077

UMIC1086

UMIC1111

NotreportedBul Bio - NCIPD Self-procurement BCG vaccine EURO HIC1090

bOPV 10-dose Chumakov FederalScientific Center Self-procurement Unknown EURO UMIC1112

GlaxoSmithKlineBiologicals SA Self-procurement Polio Sabin One and Three EMRO UMIC1139

PT Bio Farma(Persero) Other Bivalent Oral Poliomyelitis Vaccine

Type 1&3 (bOPV 1&3) SEARO LMIC1047

Sanofi Pasteur (Sub)regionalpool-procurementUnknown EMRO HIC1106

Self-procurement Unknown EURO UMIC1086

Serum Institute ofIndia Self-procurement Poliomyelitis Vaccine (Oral),Bivalent types 1 and 3 EMRO LMIC1043

15-dose Razi Institute Self-procurement bOPV vaccine EMRO UMIC1119

20-dose Bharat BiotechInternational LimitedSelf-procurement BIOPOLIO B1/3 SEARO LMIC1072

BIRMEX Self-procurement Vacuna Antipoliomielítica BivalenteOral AMRO UMIC1116

Panacea Biotec Ltd. Self-procurement Unknown SEARO LMIC1072

POLYVAC Self-procurement Unknown WPRO LMIC1018

EMRO LMIC1092

$5.50

$0.21

$0.14

$0.48

$0.55

$0.12

$0.15

$0.53

$0.60

$1.80

$1.03

$0.13

$0.21

$1.40

$0.25

$1.76

$0.16

$0.09

$0.07

$0.19

$0.07

$0.08

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 28

Page 29: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

bOPV 20-dosePOLYVAC Self-procurement Unknown WPRO LMIC1018

PT Bio Farma(Persero)

Self-procurement Bivalent Oral Poliomyelitis VaccineType 1&3 (bOPV 1&3)

EMRO LMIC1092

SEARO UMIC1074

Sanofi Pasteur Self-procurement Unknown AFRO UMIC1104

UMIC1175

UMIC1067

LMIC1142

EMRO HIC1171

HIC1007

HIC1098

EURO UMIC1077

UMIC1087

UMIC1176

UMIC1111

SEARO LMIC1150

DT 1-dose IBSS Biomed Self-procurement Unknown EURO HIC1088

Sanofi Pasteur Self-procurement DT VAX EURO HIC1137

Serum Institute ofIndia

Self-procurement Diphtheria and Tetanus VaccineAdsorbed (Paediatric)

AFRO UMIC1186

EMRO HIC1098

2-dose Microgen Self-procurement DIPHTHERIA AND TETANUS ANATOXIN(TOXOID)

EURO UMIC1112

UMIC1188

10-dose Bul Bio - NCIPD Self-procurement Diftet EMRO HIC1007

EURO UMIC1087

Other Adsorbed DT Vaccine SEARO LMIC1047

$0.20

$0.22

$0.37

$0.21

$0.26

$1.53

$0.27

$0.27

$0.20

$1.79

$0.17

$1.64

$1.63

$0.18

$66.99

$4.78

$0.35

$0.61

$0.18

$0.14

$0.82

$0.39

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 29

Page 30: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DT 10-doseBul Bio - NCIPD Self-procurement Diftet EURO UMIC1087

PT Bio Farma(Persero)

Other Adsorbed DT Vaccine SEARO LMIC1047

Self-procurement Adsorbed DT Vaccine EMRO LMIC1092

Razi Institute Self-procurement DT vaccine EMRO UMIC1119

Serum Institute ofIndia

Self-procurement Diphtheria and Tetanus VaccineAdsorbed (Ped)

AFRO UMIC1175

UMIC1084

LMIC1142

HIC1144

EMRO LMIC1043

HIC1171

SEARO LMIC1150

WPRO UMIC1051

Torlak Self-procurement Ditevaksal-T (DT) EURO UMIC1077

UMIC1086

UMIC1111

DTaP 1-dose Boryung Self-procurement Boryung Purified PDT Vaccine WPRO HIC1109

GlaxoSmithKlineBiologicals SA

Other Infanrix EURO UMIC1188

Self-procurement Infanrix AMRO HIC1191

HIC1001

EMRO HIC1098

EURO UMIC1176

HIC1126

HIC1088

AMRO HIC1001

$1.26

$0.34

$0.09

$4.00

$0.72

$0.10

$0.38

$2.35

$0.24

$0.32

$0.34

$0.89

$1.02

$1.40

$6.75

$15.70

$17.94

$12.70

$3.25

$16.40

$14.65

$15.16

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 30

Page 31: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTaP 1-dose

GlaxoSmithKlineBiologicals SA Self-procurement Infanrix EURO HIC1088

Sanofi Pasteur Self-procurement Tripacel AMRO HIC1001

EURO HIC1196

WPRO HIC1129

DTaP-HepB-Hib-IPV 1-dose GlaxoSmithKlineBiologicals SA

Other Infanrix hexa EURO UMIC1188

Self-procurement Infanrix hexa EMRO UMIC1139

EURO UMIC1147

UMIC1081

HIC1090

HIC1155

HIC1167

HIC1008

HIC1079

HIC1003

HIC1049

HIC1196

WPRO HIC1061

HIC1153

Sanofi Pasteur (Sub)regionalpool-procurement

Hexaxim (2 component pertussis) orVaxelis (5 component pertussis,Merck/Sanofi Pasteur)

EMRO HIC1106

OtherHexaxim (2 component pertussis) orVaxelis (5 component pertussis,Merck/Sanofi Pasteur)

EURO UMIC1188

Self-procurement Hexaxim (2 component pertussis) orVaxelis (5 component pertussis,Merck/Sanofi Pasteur)

AFRO UMIC1067

UMIC1186

AMRO HIC1191

HIC1171

$17.38

$16.18

$18.95

$40.53

$21.19

$45.52

$37.58

$47.70

$50.38

$45.67

$47.56

$44.60

$28.18

$32.87

$31.71

$89.14

$31.65

$25.07

$30.74

$23.52

$20.62

$18.82

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 31

Page 32: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTaP-HepB-Hib-IPV 1-dose Sanofi Pasteur Self-procurement Hexaxim (2 component pertussis) orVaxelis (5 component pertussis,Merck/Sanofi Pasteur)

AMRO HIC1191

EMRO HIC1171

HIC1007

HIC1098

EURO UMIC1087

UMIC1176

HIC1096

UMIC1081

LMIC1021

HIC1008

HIC1079

HIC1003

DTaP-Hib-IPV 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Infanrix-IPV/Hib EURO UMIC1147

HIC1088

Sanofi Pasteur (Sub)regionalpool-procurement

Pentaxim, Pentavac (2 componentpertussis), Pentacel (5 component)or Pediacel (5 component)

EMRO HIC1106

Self-procurement Pentaxim, Pentavac (2 componentpertussis), Pentacel (5 component)or Pediacel (5 component)

AMRO UMIC1116

HIC1001

EURO UMIC1112

UMIC1077

UMIC1087

UMIC1176

UMIC1086

UMIC1111

HIC1165

$21.00

$26.05

$23.80

$35.89

$50.38

$45.58

$20.19

$29.52

$32.78

$43.71

$39.47

$33.07

$25.08

$17.68

$57.41

$11.29

$21.96

$21.31

$17.99

$22.44

$23.71

$17.06

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 32

Page 33: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTaP-Hib-IPV 1-dose Sanofi Pasteur Self-procurement Pentaxim, Pentavac (2 componentpertussis), Pentacel (5 component)or Pediacel (5 component)

EUROUMIC1111

HIC1165

HIC1096

HIC1126

HIC1090

HIC1088

HIC1155

HIC1008

HIC1196

WPRO UMIC1051

HIC1109

DTaP-IPV 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Kinrix (for use in children age 4-6 yrsold only)

AMRO HIC1001

EURO HIC1126

HIC1088

HIC1079

WPRO HIC1061

HIC1153

Sanofi Pasteur Self-procurement Tetravac (2 component pertussis),Tetraxim (2 component) orQuadracel (5 component)

AMRO HIC1001

EMRO HIC1007

EURO UMIC1077

UMIC1188

UMIC1147

HIC1165

HIC1096

$30.59

$21.73

$14.68

$25.32

$26.61

$21.80

$30.53

$23.07

$28.13

$12.90

$40.02

$20.43

$17.45

$23.04

$27.43

$18.51

$39.57

$13.15

$17.44

$20.97

$16.32

$20.92

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 33

Page 34: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTaP-IPV 1-dose Sanofi Pasteur Self-procurement Tetravac (2 component pertussis),Tetraxim (2 component) orQuadracel (5 component)

EUROHIC1165

HIC1096

UMIC1081

HIC1137

HIC1090

HIC1050

HIC1088

HIC1167

HIC1008

WPRO HIC1109

DTwP 1-dose Biological E. Limited Self-procurement Unknown EMRO HIC1098

IBSS Biomed Self-procurementDTP-Szczepionkabloniczo-tezcowo-krztuscowaadsorbowana Biomed

EURO HIC1088

2-dose Microgen Self-procurement DTP-vaccine EURO UMIC1112

UMIC1188

10-dose Institut Pasteur Iran Self-procurement Unknown EMRO UMIC1119

PT Bio Farma(Persero) Self-procurement DTP Vaccine SEARO UMIC1074

Serum Institute ofIndia

Self-procurement Diphtheria-Tetanus-PertussisVaccine Adsorbed

AFRO UMIC1104

AMRO UMIC1116

EMRO LMIC1043

HIC1171

UMIC1139

SEARO LMIC1150

20-doseInstitute of Vaccinesand MedicalBiologicals, Vietnam

Self-procurement DTP Vaccine 10mL/vial WPRO LMIC1018

HIC1007

$17.62

$23.10

$18.49

$19.79

$18.75

$15.50

$15.39

$25.84

$20.74

$0.72

$7.94

$0.19

$0.16

$0.15

$0.46

$0.19

$1.63

$0.71

$3.82

$0.36

$0.22

$0.11

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 34

Page 35: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

DTwP 20-dose

Institute of Vaccinesand MedicalBiologicals, Vietnam Self-procurement DTP Vaccine 10mL/vial WPRO LMIC1018

DTwP-HepB-Hib 1-dose Arabio Self-procurement AraPenta EMRO HIC1007

HIC1098

Centro de IngenieriaGenetica yBiotecnologia

Self-procurement Heberpenta-L EMRO LIC1156

Serum Institute ofIndia

Self-procurement Diphtheria, Tetanus, Pertussis,Hepatitis B and Haemophilusinfluenzae type b Conjugate Vaccine

AFRO UMIC1084

HIC1144

EMRO LMIC1066

LMIC1043

UMIC1119

5-dose PT Bio Farma(Persero) Other Pentabio SEARO LMIC1047

10-dose Bharat BiotechInternational LimitedSelf-procurement ComVac5 SEARO LMIC1072

Biological E. Limited Self-procurement ComBE Five SEARO LMIC1072

LMIC1150

IndianImmunologicals Ltd Self-procurement Vaxtar 5 SEARO LMIC1072

Panacea Biotec Ltd. Self-procurement Easyfive-TT SEARO LMIC1072

Serum Institute ofIndia

Self-procurement Diphtheria, Tetanus, Pertussis,Hepatitis B and Haemophilusinfluenzae type b Conjugate VaccineAdsorbed

AFRO UMIC1175

LMIC1142

EMRO UMIC1119

SEARO LMIC1072

HepA 1-dose Butantan Self-procurement Vacina adsorvida hepatite A(inativada) AMRO UMIC1042

GlaxoSmithKlineBiologicals SA

Self-procurement Havrix 720 Junior AMRO HIC1001

EMRO HIC1007

EURO HIC1155

HIC1003

$6.45

$4.96

$6.18

$2.70

$3.40

$3.29

$2.31

$1.00

$5.53

$0.45

$1.30

$0.45

$0.45

$0.45

$1.63

$1.18

$1.20

$0.45

$8.96

$19.12

$12.97

$29.02

$18.09

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 35

Page 36: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepA 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Havrix 720 Junior EUROHIC1155

HIC1003

WPRO HIC1109

HIC1061

HIC1153

Havrix 1440 Adult AMRO HIC1001

EMRO HIC1007

EURO HIC1165

HIC1155

HIC1003

HIC1196

WPRO HIC1153

Merck Vaccines (Sub)regionalpool-procurement

VAQTA, Hepatitis A VaccineInactivated - 0.5mL EMRO HIC1106

Self-procurement VAQTA, Hepatitis A VaccineInactivated - 0.5mL

AMRO HIC1191

HIC1001

EURO HIC1165

WPRO HIC1109

VAQTA, Hepatitis A VaccineInactivated - 1mL

AMRO UMIC1042

HIC1001

EURO HIC1137

WPRO HIC1061

Sanofi Pasteur (Sub)regionalpool-procurementAvaxim 160 U Adult EMRO HIC1106

Self-procurement Avaxim 80 U Pediatric AMRO UMIC1116

WPRO HIC1109

$29.02

$24.00

$21.15

$13.41

$26.83

$19.04

$27.61

$34.36

$20.89

$27.48

$43.75

$13.83

$19.16

$9.18

$10.54

$13.41

$28.92

$13.77

$22.31

$27.69

$16.89

$13.89

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 36

Page 37: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepA 1-dose Sanofi Pasteur Self-procurement Avaxim 80 U PediatricAMRO UMIC1116

WPRO HIC1109

Avaxim 160 U Adult EMRO HIC1098

EURO UMIC1086

HIC1167

Sinovac Biotech Self-procurement Healive - 0.5ml containing 250u EMRO HIC1098

WPRO LMIC1040

Vector-BiAlgam Self-procurement Hepatitis A EURO UMIC1188

HepB 1-dose Binnopharm Other Regevac B EURO UMIC1188

Centro de IngenieriaGenetica yBiotecnologia

Self-procurement Heberbiovac HB AFRO UMIC1067

AMRO HIC1191

GlaxoSmithKlineBiologicals SA

(Sub)regionalpool-procurement

Engerix EMRO HIC1106

Engerix B 20mcg EMRO HIC1106

Self-procurement Engerix AMRO HIC1001

EMRO HIC1007

EURO UMIC1077

UMIC1087

UMIC1147

UMIC1111

HIC1165

HIC1096

HIC1137

HIC1155

HIC1167

$13.41

$82.50

$28.72

$25.84

$10.29

$7.40

$9.58

$1.54

$1.93

$3.70

$3.59

$3.99

$12.45

$4.01

$5.17

$5.54

$7.63

$11.39

$4.13

$8.87

$4.40

$2.13

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 37

Page 38: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepB 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Engerix EUROHIC1155

HIC1167

HIC1008

HIC1003

WPRO HIC1061

Engerix B 20mcg AMRO HIC1191

HIC1001

EMRO HIC1007

EURO UMIC1077

HIC1165

HIC1096

HIC1137

HIC1088

HIC1155

HIC1167

HIC1008

WPRO HIC1153

Janssen VaccinesCorp.

Self-procurement Hepavax WPRO HIC1109

Hepavax-Gene TF (thimerosal free) WPRO HIC1109

LG Chem Ltd Other Euvax B (adult) EURO UMIC1188

Self-procurement Euvax B EMRO LMIC1092

EURO UMIC1077

UMIC1086

UMIC1081

$4.27

$5.21

$12.68

$6.58

$28.27

$5.91

$4.71

$7.54

$35.03

$32.88

$10.44

$8.87

$30.53

$12.74

$5.30

$13.37

$2.06

$3.60

$8.24

$0.65

$4.79

$2.28

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 38

Page 39: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepB 1-dose LG Chem Ltd Self-procurement Euvax B EUROUMIC1086

UMIC1081

HIC1088

WPRO UMIC1051

HIC1109

Euvax B (adult) EURO UMIC1086

UMIC1111

HIC1088

WPRO UMIC1051

HIC1109

HIC1061

Merck Vaccines Self-procurement HB Vaxpro AMRO HIC1191

HIC1001

EURO HIC1003

WPRO HIC1153

HIC1129

PT Bio Farma(Persero) Other Hepatitis B Vaccine Recombinant SEARO LMIC1047

Serum Institute ofIndia

Self-procurement Hepatitis B Vaccine (rDNA) (Adult) AFRO UMIC1104

LMIC1142

UMIC1186

EMRO HIC1171

UMIC1139

HIC1098

UMIC1104

$2.09

$6.04

$2.06

$1.07

$2.62

$6.28

$7.49

$4.44

$3.60

$1.69

$12.30

$7.55

$5.44

$12.30

$17.14

$1.68

$0.97

$1.61

$0.58

$1.28

$2.75

$2.25

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 39

Page 40: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HepB 1-dose Serum Institute ofIndia

Self-procurementHepatitis B Vaccine (rDNA) (Adult) EMRO HIC1098

Hepatitis B Vaccine (rDNA) (Ped) AFRO UMIC1104

UMIC1175

AMRO UMIC1116

EMRO LMIC1043

LMIC1092

HIC1171

HIC1098

VABIOTECH Self-procurement Hepatitis B vaccine 0.5 ml WPRO LMIC1018

2-dose LG Chem Ltd Self-procurement Euvax B EURO UMIC1176

5-doseCentro de IngenieriaGenetica yBiotecnologia

Self-procurement Heberbiovac HB EURO UMIC1188

10-dose Butantan Self-procurement Vacina adsorvida hepatite B(recombinante) AMRO UMIC1042

Institut Pasteur Iran Self-procurement Recombinant hepatitis B vaccine EMRO UMIC1119

Serum Institute ofIndia

Self-procurement Hepatitis B Vaccine (rDNA) (Adult) AMRO UMIC1116

EMRO LMIC1092

Hepatitis B Vaccine (rDNA) (Ped) AFRO UMIC1084

Notreported

Serum Institute ofIndia Self-procurement Unknown SEARO UMIC1074

Hib 1-dose GlaxoSmithKlineBiologicals SA

Other Hiberix EURO UMIC1188

Self-procurement Hiberix AMRO HIC1001

EMRO LMIC1092

EURO UMIC1112

UMIC1188

HIC1155

HIC1167

$3.05

$0.25

$1.09

$2.35

$1.30

$0.65

$0.40

$0.36

$1.20

$0.90

$0.52

$0.23

$1.10

$0.81

$0.20

$0.58

$8.18

$9.56

$2.81

$7.63

$5.80

$6.66

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 40

Page 41: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Hib 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Hiberix EUROHIC1155

HIC1167

HIC1008

WPRO HIC1109

HIC1061

HIC1153

LG Chem Ltd Self-procurement Euhib WPRO HIC1109

Merck Vaccines Self-procurement Pedvax HIB AMRO HIC1001

Sanofi Pasteur Self-procurement Act-HIB AFRO UMIC1104

AMRO HIC1191

HIC1001

EMRO HIC1171

HIC1007

HIC1098

EURO UMIC1087

UMIC1111

HIC1137

HIC1090

HIC1088

HIC1155

HIC1003

HIC1196

WPRO HIC1109

Serum Institute ofIndia

Self-procurement Hemophilus influenzae type bConjugated Vaccine

EMRO UMIC1119

$9.05

$14.41

$13.71

$14.49

$5.11

$5.11

$12.93

$3.29

$9.42

$35.01

$12.00

$6.18

$9.50

$19.00

$10.01

$8.22

$6.40

$23.49

$7.10

$8.45

$7.66

$5.11

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 41

Page 42: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Hib 1-doseSanofi Pasteur Self-procurement Act-HIB WPRO HIC1109

Serum Institute ofIndia Self-procurement Hemophilus influenzae type bConjugated Vaccine EMRO UMIC1119

NotreportedMerck Vaccines Self-procurement Pedvax HIB WPRO HIC1129

HPV 1-dose GlaxoSmithKlineBiologicals SA

Other Cervarix EURO UMIC1188

Self-procurement Cervarix AFRO UMIC1067

UMIC1186

AMRO UMIC1116

EURO UMIC1087

HIC1096

HIC1126

HIC1050

HIC1049

SEARO UMIC1074

WPRO UMIC1051

HIC1109

Merck Vaccines Other Gardasil EURO UMIC1188

SEARO LMIC1047

Self-procurement Gardasil AFRO UMIC1084

HIC1144

AMRO HIC1108

UMIC1042

HIC1191

EURO HIC1165

HIC1137

$4.52

$13.09

$61.69

$20.43

$10.46

$8.17

$34.24

$22.90

$24.22

$24.07

$22.77

$8.50

$51.09

$7.64

$115.40

$11.56

$25.00

$13.79

$13.23

$11.01

$8.32

$46.46

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 42

Page 43: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

HPV 1-dose Merck Vaccines Self-procurement Gardasil EUROHIC1165

HIC1137

HIC1090

HIC1155

HIC1008

HIC1003

HIC1196

SEARO UMIC1074

WPRO HIC1109

HIC1061

Gardasil 9 AMRO HIC1001

EURO HIC1155

HIC1167

WPRO HIC1153

Unknown WPRO HIC1129

Notreported

GlaxoSmithKlineBiologicals SA Self-procurement Unknown EURO HIC1196

IPV 1-dose Bilthoven BiologicalsSelf-procurement Poliomyelitis vaccine EMRO LMIC1043

Korea Vaccine Self-procurement Kovax Polio PF Inj WPRO HIC1109

Sanofi Pasteur (Sub)regionalpool-procurementIMOVAX POLIO EMRO HIC1106

Self-procurement IMOVAX POLIO EMRO LMIC1092

UMIC1119

HIC1171

HIC1007

UMIC1188

$142.19

$55.45

$46.97

$42.10

$50.92

$62.11

$11.59

$16.19

$57.17

$145.33

$78.98

$57.54

$97.02

$168.10

$128.38

$2.98

$7.75

$5.03

$8.82

$5.25

$6.11

$8.42

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 43

Page 44: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

IPV 1-dose Sanofi Pasteur Self-procurement IMOVAX POLIOEMRO HIC1007

EURO UMIC1188

UMIC1086

HIC1165

HIC1137

HIC1050

HIC1088

HIC1155

HIC1167

HIC1008

HIC1003

SEARO UMIC1074

WPRO HIC1061

HIC1153

Serum Institute ofIndia Self-procurement Poliomyelitis Vaccine (Inactivated) EMRO HIC1098

5-dose Bilthoven BiologicalsSelf-procurement Poliomyelitis vaccine multidose,suspension for injection 2.5 mL EURO UMIC1112

Shantha BiotechnicsPrivate Limited (ASanofi Company)

Other ShanIPV SEARO LMIC1047

10-dose Bio-Manguinhos/Fio..Self-procurement Poliomyelitis 1, 2 and 3 (inactivated)AMRO UMIC1042

Sanofi Pasteur Self-procurement IMOVAX POLIO AFRO UMIC1175

LMIC1142

EMRO UMIC1119

WPRO LMIC1016

Notreported

Sanofi Pasteur Self-procurement Unknown AMRO HIC1001

HIC1090

$5.27

$11.27

$8.24

$7.05

$6.26

$17.17

$7.75

$12.51

$6.33

$5.28

$8.61

$27.43

$42.89

$9.50

$4.37

$11.14

$2.78

$19.48

$1.56

$4.70

$2.12

$13.19

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 44

Page 45: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

IPV Notreported

Sanofi Pasteur Self-procurement UnknownAMRO HIC1001

EURO HIC1090

HIC1196

WPRO HIC1129

JE 1-dose Boryung Self-procurementBoryung Cell culture-derivedJapanese Encephalitis Vaccine(injection)

WPRO HIC1109

Chengdu Institute ofBiological ProductsCo.,Ltd

Self-procurement Japanese Encephalitis Vaccine Live(SA14-14-2)

SEARO UMIC1074

WPRO HIC1109

GPO-MBP Co., Ltd. Self-procurement IMOJEV MD WPRO UMIC1051

HIC1061

Valneva Self-procurement Ixiaro EURO HIC1008

4-dose GPO-MBP Co., Ltd. Self-procurement IMOJEV MD SEARO UMIC1074

5-dose Biological E. Limited Self-procurement JEEV SEARO LMIC1072

Chengdu Institute ofBiological ProductsCo.,Ltd

Other Japanese Encephalitis Vaccine Live(SA14-14-2) SEARO LMIC1047

Self-procurement Japanese Encephalitis Vaccine Live(SA14-14-2)

SEARO LIC1004

LMIC1150

10-dose VABIOTECH Self-procurementJapanese Encephalitis vaccine - techtransfer from BIKEN Institute,Japan5mL

WPRO LMIC1018

Measles 1-dose Microgen Self-procurement Measles vaccine EURO UMIC1112

Serum Institute ofIndia

Self-procurement Measles Vaccine, Live attenuated EMRO UMIC1139

HIC1098

10-dose POLYVAC Self-procurementMeasles vaccine. Freeze-dried, liveattenuated vaccine. AIK-C Strain5mL

WPRO LMIC1018

Serum Institute ofIndia

Self-procurement Measles Vaccine, Live attenuated AFRO LIC1041

EMRO UMIC1139

WPRO UMIC1051

Arabio Self-procurement Aramen : Conjugated MeningitisACWY Vaccine (tech transfer)

EMRO HIC1007

$4.37

$14.09

$13.30

$10.40

$4.99

$10.46

$37.27

$11.89

$73.56

$4.57

$0.46

$3.50

$0.76

$0.62

$0.46

$0.54

$3.90

$4.15

$0.24

$0.99

$6.61

$0.80

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 45

Page 46: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Measles 10-doseSerum Institute ofIndia Self-procurement Measles Vaccine, Live attenuated WPRO UMIC1051

MenACYW-135 1-dose Arabio Self-procurement Aramen : Conjugated MeningitisACWY Vaccine (tech transfer) EMRO HIC1007

GlaxoSmithKlineBiologicals SA

Self-procurement Menveo AMRO HIC1191

EURO HIC1167

HIC1003

HIC1196

WPRO HIC1061

Pfizer Self-procurement Nimenrix EURO HIC1088

HIC1155

HIC1008

HIC1196

WPRO HIC1153

Sanofi Pasteur Self-procurement Menactra AFRO UMIC1186

EMRO UMIC1119

HIC1098

EURO UMIC1134

WPRO HIC1153

MenACYW-135 Ps 1-dose Sanofi Pasteur Self-procurement Menomune EMRO HIC1171

EURO UMIC1111

WPRO UMIC1051

Notreported

GlaxoSmithKlineBiologicals SA Self-procurement Unknown EMRO LMIC1092

MenB 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Bexsero (ex Novartis product) AMRO HIC1001

EURO HIC1050

HIC1088

$16.21

$24.11

$59.33

$46.70

$41.69

$28.25

$59.33

$39.34

$30.73

$37.28

$47.28

$21.17

$19.49

$17.62

$26.33

$61.68

$8.10

$119.56

$24.28

$6.93

$106.42

$64.60

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 46

Page 47: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

MenB 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Bexsero (ex Novartis product) EUROHIC1050

HIC1088

HIC1155

HIC1167

HIC1008

HIC1003

HIC1049

HIC1196

Pfizer Self-procurement Trumenba AMRO HIC1001

MenC 1-dose FUNED Self-procurement MenC vaccine AMRO UMIC1042

GlaxoSmithKlineBiologicals SA

Null Menjugate (ex Novartis product) AMRO HIC1035

Self-procurement Menjugate (ex Novartis product) EURO HIC1008

HIC1196

Pfizer Self-procurement NeisVac-C (ex-Baxter product) EURO HIC1126

HIC1137

HIC1088

HIC1049

HIC1196

WPRO HIC1153

MMR 1-dose GlaxoSmithKlineBiologicals SA

(Sub)regionalpool-procurementPriorix EMRO HIC1106

Self-procurement Priorix AFRO UMIC1186

EMRO UMIC1139

HIC1007

UMIC1077

$103.52

$79.86

$102.61

$84.60

$78.29

$84.55

$85.00

$90.38

$10.37

$101.50

$26.36

$12.32

$26.36

$20.55

$27.82

$25.25

$15.55

$34.28

$6.39

$8.08

$6.61

$5.65

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 47

Page 48: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

MMR 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement PriorixEMRO HIC1007

EURO UMIC1077

UMIC1087

UMIC1086

UMIC1111

HIC1165

HIC1155

HIC1167

HIC1079

HIC1003

HIC1049

HIC1196

SEARO UMIC1074

WPRO UMIC1051

HIC1109

HIC1061

HIC1153

Merck Vaccines (Sub)regionalpool-procurementrHA M-M-R II EMRO HIC1106

Self-procurement rHA M-M-R II AMRO HIC1001

EMRO HIC1171

EURO UMIC1147

UMIC1111

HIC1096

HIC1126

$16.03

$8.34

$5.60

$11.10

$12.45

$7.16

$6.26

$7.49

$7.46

$5.95

$6.68

$5.57

$17.14

$13.01

$10.34

$4.03

$6.39

$32.30

$6.80

$7.12

$6.83

$7.42

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 48

Page 49: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

MMR 1-dose Merck Vaccines Self-procurement rHA M-M-R II EUROHIC1096

HIC1126

UMIC1081

HIC1137

HIC1090

HIC1088

HIC1008

HIC1196

WPRO HIC1109

Serum Institute ofIndia

(Sub)regionalpool-procurement

Measles,Mumps and Rubella VaccineLive attenuated EMRO HIC1106

Self-procurement Measles,Mumps and Rubella VaccineLive attenuated

AFRO HIC1144

EMRO HIC1098

EURO UMIC1176

2-dose GlaxoSmithKlineBiologicals SA Self-procurement Priorix EURO UMIC1188

Serum Institute ofIndia Self-procurement Measles,Mumps and Rubella VaccineLive attenuated EMRO UMIC1119

5-dose Razi Institute Self-procurement MMR EMRO UMIC1119

10-dose Serum Institute ofIndia

Other Measles,Mumps and Rubella VaccineLive attenuated AMRO UMIC1133

Self-procurement Measles,Mumps and Rubella VaccineLive attenuated

AFRO UMIC1104

AMRO UMIC1116

EMRO LMIC1092

SEARO LMIC1150

NotreportedBio-Manguinhos/Fio..Self-procurement Measles, mumps and rubella (MMR) AMRO UMIC1042

MMRV 1-dose Merck Vaccines Self-procurement ProQuad AMRO HIC1001

EURO HIC1079

$16.03

$7.40

$6.44

$6.91

$7.05

$6.49

$7.92

$10.34

$6.39

$3.75

$5.65

$3.50

$4.00

$3.05

$1.47

$1.08

$1.63

$5.06

$1.57

$1.40

$2.77

$122.44

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 49

Page 50: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

MMRV 1-dose Merck Vaccines Self-procurement ProQuadAMRO HIC1001

EURO HIC1079

MR 1-dose Serum Institute ofIndia

Self-procurement Measles and Rubella Vaccine, Live,Attenuated

AFRO UMIC1084

EMRO LMIC1043

10-dose Biological E. Limited Self-procurement MRBEV SEARO LMIC1072

POLYVAC Self-procurement MRVAC WPRO LMIC1018

Razi Institute Self-procurement MR EMRO UMIC1119

Serum Institute ofIndia

Other Measles and Rubella Virus VaccineLive SEARO LMIC1047

Self-procurement Measles and Rubella Virus VaccineLive

AFRO UMIC1175

LMIC1142

AMRO UMIC1116

EMRO LMIC1043

SEARO LMIC1072

WPRO UMIC1051

PCV 1-dose GlaxoSmithKlineBiologicals SA

Other Synflorix EURO UMIC1188

Self-procurement Synflorix AMRO UMIC1042

EURO UMIC1188

UMIC1147

UMIC1111

HIC1096

HIC1126

HIC1137

HIC1088

HIC1155

$11.10

$3.04

$2.58

$0.55

$0.66

$1.17

$10.91

$0.86

$1.84

$2.17

$0.75

$0.55

$10.28

$27.35

$14.91

$21.18

$33.94

$35.66

$33.30

$26.85

$31.42

$26.00

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 50

Page 51: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

PCV 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Synflorix EUROHIC1088

HIC1155

HIC1079

WPRO UMIC1063

HIC1109

HIC1153

HIC1129

Pfizer (Sub)regionalpool-procurementPrevnar 13 EMRO HIC1106

Other Prevnar 13 EURO UMIC1188

SEARO LMIC1047

Self-procurement Prevnar 13 AFRO UMIC1104

UMIC1175

UMIC1084

UMIC1067

LMIC1142

UMIC1186

HIC1144

AMRO HIC1108

UMIC1116

HIC1191

HIC1162

HIC1001

EMRO HIC1171

HIC1007

$44.80

$27.01

$131.77

$96.00

$47.84

$15.15

$26.18

$60.57

$18.56

$45.90

$29.02

$19.51

$18.45

$16.63

$15.21

$15.77

$122.07

$25.00

$15.76

$9.56

$7.04

$26.25

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 51

Page 52: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

PCV 1-dose Pfizer Self-procurement Prevnar 13 EMROHIC1171

HIC1007

HIC1098

EURO UMIC1112

UMIC1176

UMIC1086

UMIC1111

UMIC1081

HIC1088

HIC1155

HIC1167

HIC1008

HIC1079

HIC1049

HIC1196

WPRO LMIC1016

HIC1109

HIC1061

HIC1153

4-dose Pfizer Self-procurement Prevnar 13 EURO HIC1003

PPSV 1-dose Merck Vaccines (Sub)regionalpool-procurementPneumovax 23 EMRO HIC1106

Self-procurement Pneumovax 23 AMRO UMIC1116

UMIC1042

HIC1191

$26.25

$26.30

$64.85

$51.67

$63.66

$53.70

$58.82

$51.67

$41.42

$45.80

$27.30

$63.77

$26.11

$19.04

$99.42

$66.55

$55.56

$15.53

$55.05

$14.69

$8.86

$8.06

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 52

Page 53: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

PPSV 1-dose Merck Vaccines Self-procurement Pneumovax 23 AMROUMIC1042

HIC1191

EMRO HIC1007

HIC1098

EURO HIC1137

HIC1155

HIC1008

WPRO HIC1109

HIC1061

HIC1153

Sanofi Pasteur Self-procurement Pneumo 23 EURO HIC1167

HIC1003

HIC1196

Rabies 1-dose Bharat BiotechInternational Limited

Self-procurement Indirab AMRO HIC1191

EURO UMIC1176

Butantan Self-procurement inactivated rabies vaccine(VR/VERO)

AMRO UMIC1042

Chiron BehringVaccines Private Ltd.

Self-procurement Rabipur EURO HIC1008

HIC1003

Chumakov FederalScientific Center Self-procurement Rabies Vaccine EURO UMIC1188

Sanofi Pasteur Self-procurement VERORAB AMRO HIC1191

EMRO UMIC1119

UMIC1139

HIC1007

UMIC1077

$8.75

$20.02

$13.02

$30.59

$18.93

$27.76

$24.18

$34.75

$18.71

$14.63

$17.46

$22.70

$5.91

$3.70

$13.33

$57.11

$52.85

$6.63

$13.30

$15.53

$21.19

$7.90

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 53

Page 54: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Rabies 1-dose Sanofi Pasteur Self-procurement VERORABEMRO HIC1007

EURO UMIC1077

UMIC1086

UMIC1147

HIC1165

HIC1096

HIC1137

HIC1050

HIC1088

HIC1155

HIC1003

WPRO HIC1061

Serum Institute ofIndia

Self-procurement Rabies Vaccine Inactivated (FreezeDried) (RABIVAX-5)

EMRO UMIC1119

HIC1098

Rota 1-dose GlaxoSmithKlineBiologicals SA

(Sub)regionalpool-procurementRotarix EMRO HIC1106

Self-procurement Rotarix AFRO UMIC1175

UMIC1084

UMIC1067

LMIC1142

UMIC1186

HIC1144

AMRO UMIC1042

HIC1001

EMRO HIC1007

$95.90

$16.44

$20.85

$16.16

$20.67

$18.20

$23.71

$16.93

$26.58

$29.91

$86.34

$10.70

$6.81

$12.00

$13.80

$16.96

$9.41

$7.91

$9.50

$9.97

$91.77

$8.12

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 54

Page 55: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Rota 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement RotarixAMRO HIC1001

EMRO HIC1007

WPRO UMIC1063

HIC1153

Merck Vaccines (Sub)regionalpool-procurementRotateq EURO HIC1050

Self-procurement Rotateq AMRO UMIC1116

HIC1001

EMRO UMIC1139

HIC1098

LMIC1060

EURO HIC1096

HIC1003

5-dose Bharat BiotechInternational LimitedSelf-procurement Rotavac SEARO LMIC1072

Seasonal Influenza 1-dose Abbott Biologicals Other Unknown EURO UMIC1188

Self-procurement Unknown AFRO UMIC1067

AMRO HIC1191

EMRO HIC1171

HIC1007

HIC1098

EURO HIC1126

UMIC1081

HIC1050

HIC1003

SEARO UMIC1074

$11.02

$27.43

$7.35

$9.24

$69.77

$3.80

$12.30

$6.50

$4.75

$13.83

$9.78

$0.82

$4.32

$4.97

$2.78

$2.79

$3.05

$3.25

$3.00

$4.17

$2.84

$2.86

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 55

Page 56: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Seasonal Influenza 1-dose Abbott Biologicals Self-procurement UnknownEURO HIC1003

SEARO UMIC1074

Boryung Self-procurement Unknown WPRO HIC1109

GlaxoSmithKlineBiologicals SA Self-procurement Unknown EURO HIC1167

Green CrossCorporation

Self-procurement Unknown EMRO UMIC1119

WPRO HIC1109

Hualan BiologicalBacterin Co., Ltd Other Unknown EURO UMIC1159

Il-YandPharmaceutical Self-procurement Unknown WPRO HIC1109

Korea Vaccine Self-procurementKovax Flu tetra, Kovax Influ tetra,Kovax - flu, Kovax - Influ, Influ-Kovax

WPRO HIC1109

Microgen Other Unknown EURO UMIC1188

Self-procurement Unknown EURO UMIC1112

Petrovax Other Unknown EURO UMIC1188

Self-procurement Unknown EURO UMIC1188

Sanofi Pasteur Other Unknown EMRO HIC1106

EURO UMIC1188

Self-procurement Unknown AFRO UMIC1186

AMRO HIC1191

EMRO UMIC1119

UMIC1139

EURO UMIC1077

UMIC1134

HIC1165

HIC1137

HIC1155

$3.10

$8.01

$6.69

$4.58

$8.01

$0.75

$8.22

$8.01

$2.48

$2.22

$1.88

$1.88

$2.94

$6.40

$3.32

$3.32

$4.08

$4.76

$3.34

$8.20

$3.47

$6.27

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 56

Page 57: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Seasonal Influenza 1-dose Sanofi Pasteur Self-procurement Unknown EUROHIC1137

HIC1155

HIC1167

HIC1196

WPRO HIC1109

HIC1061

Seqirus Limited Self-procurement Unknown AMRO HIC1108

EURO HIC1167

WPRO LMIC1089

SK Bioscience Co.,Ltd. Self-procurement Unknown WPRO HIC1109

4-dose GPO-MBP Co., Ltd. Self-procurement Unknown SEARO UMIC1074

10-dose Butantan Self-procurement Unknown AMRO UMIC1042

Sanofi Pasteur Self-procurement Unknown AMRO UMIC1116

NotreportedSanofi Pasteur Self-procurement Unknown EURO UMIC1111

TBE 1-dose Bavarian Nordic Self-procurement Encepur EURO HIC1096

HIC1155

Chumakov FederalScientific Center Other Unknown EURO UMIC1188

Microgen Other EnceVir EURO UMIC1188

Self-procurement EnceVir EURO UMIC1176

UMIC1188

Pfizer Self-procurement TicoVac (0.5ml) (ex-Baxter product)EURO HIC1155

Ticovac Junior (0.25ml) (ex-Baxterproduct)

EURO HIC1096

HIC1155

HIC1109

$5.97

$6.75

$5.73

$5.92

$8.01

$2.44

$9.17

$1.50

$8.01

$3.03

$4.12

$2.80

$4.17

$20.79

$15.89

$8.01

$8.55

$4.61

$6.08

$21.57

$20.20

$16.46

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 57

Page 58: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

TBE 1-dose Pfizer Self-procurementTicovac Junior (0.25ml) (ex-Baxterproduct) EURO HIC1155

Td 1-dose AJ Vaccine Self-procurement diTeBooster (0.5 ml) (former SSI -Statens Serum Institut)

WPRO HIC1109

HIC1153

Bul Bio - NCIPD Self-procurement Tetadif EURO UMIC1147

IBSS Biomed Self-procurement Clodivac EURO UMIC1077

HIC1088

HIC1003

MassBiologics Self-procurement Td AMRO HIC1001

Sanofi Pasteur Self-procurement IMOVAX dT adult AMRO HIC1001

EURO HIC1096

HIC1090

HIC1008

HIC1003

Serum Institute ofIndia

(Sub)regionalpool-procurement

Diphtheria and Tetanus VaccineAdsorbed for Adults and AdolescentsEMRO HIC1106

Self-procurement Diphtheria and Tetanus VaccineAdsorbed for Adults and Adolescents

AFRO UMIC1104

EMRO HIC1007

HIC1098

2-dose Microgen Self-procurement DIPHTHERIA AND TETANUS ANATOXIN(TOXOID), REDUCED ANTIGENCONTENT

EURO UMIC1112

UMIC1188

10-dose Biological E. Limited Self-procurement BE Td EMRO UMIC1139

SEARO LMIC1072

UMIC1074

Bul Bio - NCIPD Self-procurement Tetadif EURO UMIC1087

HIC1096

$11.64

$11.51

$0.83

$11.43

$2.24

$5.54

$13.12

$19.88

$11.43

$4.46

$8.24

$9.75

$4.98

$0.13

$0.56

$1.22

$0.09

$0.07

$0.42

$0.17

$0.12

$0.36

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 58

Page 59: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Td 10-dose Bul Bio - NCIPD Self-procurement Tetadif EUROUMIC1087

HIC1096

Finlay Other diTe-Vax AMRO UMIC1010

PT Bio Farma(Persero) Other Unknown SEARO LMIC1047

Razi Institute Self-procurement Td vaccine EMRO UMIC1119

Sanofi Pasteur Self-procurement IMOVAX dT adult AFRO UMIC1067

Serum Institute ofIndia

Self-procurement Diphtheria and Tetanus VaccineAdsorbed for Adultsand Adolescents

AMRO UMIC1116

EMRO LMIC1043

LMIC1092

HIC1171

SEARO LIC1004

LMIC1150

Torlak Self-procurement Ditevaksal-T (Td) EURO UMIC1077

UMIC1086

UMIC1111

Tdap 1-dose AJ Vaccine Self-procurement TdapBooster EURO HIC1088

Butantan Self-procurement Tdap, in partnership with GSK AMRO UMIC1042

GlaxoSmithKlineBiologicals SA

Self-procurement Boostrix AMRO HIC1001

EMRO HIC1171

HIC1007

EURO HIC1165

HIC1050

HIC1155

HIC1167

$3.82

$0.13

$1.19

$0.09

$0.86

$0.37

$2.35

$0.31

$0.15

$0.23

$0.08

$0.89

$1.02

$1.40

$17.27

$10.36

$28.00

$12.22

$12.20

$15.82

$15.51

$17.15

$16.17

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 59

Page 60: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Tdap 1-dose GlaxoSmithKlineBiologicals SA

Self-procurement Boostrix EUROHIC1155

HIC1167

HIC1008

HIC1003

WPRO HIC1109

HIC1153

HIC1129

Sanofi Pasteur Self-procurement Adacel, Covaxis, Trivaxis AMRO UMIC1116

HIC1001

EURO HIC1090

WPRO HIC1109

TT 1-dose IBSS Biomed Self-procurement Tetana (0.5 ml) EURO HIC1088

Sanofi Pasteur Self-procurement Imovax tetano AFRO UMIC1186

EURO HIC1003

Serum Institute ofIndia Self-procurement Unknown WPRO HIC1061

Torlak Self-procurement Tetavaksal-T EURO UMIC1077

UMIC1086

UMIC1111

2-dose Microgen Self-procurement TETANUS ANATOXIN (TOXOID) EURO UMIC1112

UMIC1188

10-dose Biological E. Limited Self-procurement BEtt AFRO LIC1041

EMRO LMIC1092

Bul Bio - NCIPD Self-procurement Tetatox EURO UMIC1087

PT Bio Farma(Persero)

Self-procurement TT vaccine WPRO UMIC1051

$28.77

$15.51

$15.82

$31.37

$17.14

$17.88

$27.88

$10.77

$16.45

$17.88

$2.24

$1.00

$7.69

$3.55

$1.46

$1.66

$2.33

$0.09

$0.07

$0.10

$0.31

$0.33

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 60

Page 61: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

TT 10-doseBul Bio - NCIPD Self-procurement Tetatox EURO UMIC1087

PT Bio Farma(Persero) Self-procurement TT vaccine WPRO UMIC1051

Sanofi Pasteur Self-procurement TETAVAX AFRO UMIC1067

LMIC1142

Serum Institute ofIndia

Self-procurement Tetanus Toxoid Vaccine Adsorbed AFRO UMIC1175

UMIC1084

EMRO LMIC1092

HIC1171

UMIC1139

20-doseInstitute of Vaccinesand MedicalBiologicals, Vietnam

Self-procurement TT vaccine 10ml/vial WPRO LMIC1018

Typhoid Ps 1-dose Boryung Self-procurement Zerotyph Cap. WPRO HIC1109

PaxVax Self-procurement Vivotif (ex-Crucell vaccine) EURO HIC1167

Sanofi Pasteur Self-procurement Typhym-Vi AFRO UMIC1186

EMRO HIC1007

HIC1098

EURO UMIC1147

HIC1137

HIC1167

HIC1008

HIC1003

HIC1196

WPRO HIC1061

20-dose IBSS Biomed Self-procurement Ty -typhoid vaccine EURO HIC1088

Sanofi Pasteur Self-procurement Typhym-Vi EMRO HIC1171

$0.25

$0.34

$0.63

$0.10

$0.36

$0.18

$0.23

$0.31

$0.05

$4.41

$10.97

$9.05

$8.00

$8.00

$50.04

$20.68

$15.27

$11.38

$15.50

$12.61

$9.61

$20.05

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 61

Page 62: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

Typhoid Ps 20-doseIBSS Biomed Self-procurement Ty -typhoid vaccine EURO HIC1088

Sanofi Pasteur Self-procurement Typhym-Vi EMRO HIC1171

Varicella 1-doseChina NationalBiotech GroupKeygen

Self-procurement Unknown WPRO HIC1109

GlaxoSmithKlineBiologicals SA

Self-procurement Varilrix EMRO HIC1007

EURO HIC1088

HIC1167

HIC1049

HIC1196

WPRO HIC1153

Green CrossCorporation Self-procurement Varicella Vaccine-GCC inj. WPRO HIC1109

Merck Vaccines Self-procurement Varivax AMRO UMIC1116

UMIC1042

HIC1001

EMRO UMIC1119

HIC1171

HIC1098

EURO HIC1096

HIC1090

HIC1155

HIC1196

SK Bioscience Co.,Ltd. Self-procurement SKY Varicella Inj. WPRO HIC1109

YF 1-dose Sanofi Pasteur Self-procurement Stamaril AFRO LMIC1142

UMIC1186

AMRO HIC1191

$4.05

$11.59

$24.65

$46.89

$34.14

$45.07

$45.56

$34.28

$11.59

$72.18

$20.43

$17.87

$22.49

$20.00

$27.60

$150.29

$36.40

$23.48

$25.40

$11.59

$15.29

$21.30

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 62

Page 63: MI4A Vaccine Purchase Data for Countries...Global Vaccine Market Report is published annually, offering global insights on vaccine markets. 3 MI4A also develops vaccine-specific Global

YF 1-dose Sanofi Pasteur Self-procurement StamarilAFRO UMIC1186

AMRO HIC1191

EMRO LMIC1092

UMIC1119

HIC1171

UMIC1139

HIC1007

HIC1098

EURO UMIC1086

HIC1137

HIC1008

WPRO HIC1061

2-dose Chumakov FederalScientific Center Self-procurement YELLOW FEVER VACCINE LIVEFREEZE-DRIED EURO UMIC1188

10-dose Chumakov FederalScientific Center Self-procurement YELLOW FEVER VACCINE LIVEFREEZE-DRIED AMRO LMIC1123

NotreportedBio-Manguinhos/Fio..Self-procurement Yellow Fever AMRO UMIC1042

$43.25

$20.00

$20.04

$40.96

$19.50

$19.08

$18.80

$23.49

$24.93

$31.82

$84.30

$7.21

$3.05

$1.08

WORKING DOCUMENT - MI4A Vaccine Purchase Data Note [December 2019] | 63